Introduction {#s1}
============

The endoplasmic reticulum (ER) in eukaryotic cells is a vast and distributed intracellular network of membranous tubes and sheets with essential roles in ion and lipid homeostasis. It exerts many of its functions through intimate membrane contact sites (MCSs) with other organelles ([@bib42]). MCSs are regions where organelles typically come within 10 to 30 nm of one another and are thought to be specialized 'microdomains' that selectively localize lipid and protein effectors that function in signaling pathways and organelle dynamics ([@bib17]; [@bib37]; [@bib45]).

MCSs between the ER and the plasma membrane (ER-PM) are a highly conserved feature of eukaryotic cells and have emerged as key regulators of intracellular Ca^2+^ dynamics ([@bib7]; [@bib13]; [@bib17]; [@bib25]; [@bib45]; [@bib51]). In particular, in metazoan cells the store operated calcium entry pathway (SOCE) is critical for maintaining cellular Ca^2+^ homeostasis and is activated by the depletion of Ca^2+^ stores in the ER, which triggers extracellular Ca^2+^ influx through the PM at ER-PM contact sites to refill ER lumen Ca^2+^ stores ([@bib5]; [@bib31]). [S]{.ul}tromal-[I]{.ul}nteracting [M]{.ul}olecule [1]{.ul} (STIM1) protein is an integral ER protein that regulates SOCE in response to luminal ER Ca^2+^. A decrease in intraluminal ER Ca^2+^ is sensed by STIM1, which undergoes conformational changes that expose domains that promote oligomerization and transport/targeting to pre-existing phosphatidylinositol 4,5-biphosphate (PI(4,5)P2) enriched ER-PM MCSs ([@bib5]; [@bib56]; [@bib59]). At PI(4,5)P2-enriched ER-PM contacts, STIM1 directly recruits and activates PM Orai1 Ca^2+^ channels, which replenish ER Ca^2+^ ([@bib5]; [@bib7]; [@bib35]; [@bib49]).

Highly conserved ER-PM tethers have been described and include the yeast tricalbins/human extended synaptotagmins (E-Syt) ([@bib22]; [@bib36]; [@bib46]). Mammalian E-Syt1/2/3 are anchored to the ER via an N-terminal hydrophobic hairpin and possess repeating cytosolic C2 domains, which directly mediate contact between the ER and the PM via interactions with PM-enriched PI(4,5)P2 lipids ([@bib22]). In addition, they contain [S]{.ul}ynaptotagmin-like, [M]{.ul}itochondrial and lipid-binding [P]{.ul}rotein (SMP) domains, which mediate their homo- and hetero-oligomerization and facilitate glycerolipid transport -- a function implicated during PLC activation in the transport and recycling of diacylglycerol from the PM to the ER in mammalian cells ([@bib19]; [@bib44]; [@bib48]). E-Syt2/3 tether the ER to the PM at resting Ca^2+^ levels, while E-Sty1 is recruited to ER-PM in a manner dependent on conditions of high intracellular Ca^2+^, as observed during SOCE where E-Syt1 stabilizes and expands Ca^2+^-specific microdomains ([@bib6]; [@bib35]). During SOCE, STIM1 and Orai1 are recruited to a subset of E-Syts-containing ER-PM contact sites; however, the E-Syts are not required for any events in the SOCE pathway ([@bib22]). In addition, cells lacking all three known E-Syts (1/2/3) still possess 50% of the ER-PM contact area relative to wild type cells ([@bib22]; [@bib44]). These observations suggest that additional ER-PM tethers exist and potentially function to specialize ER-PM contacts ([@bib45]).

A highly conserved family of ER membrane Ltc/Lam proteins was recently described ([@bib18]; [@bib21]; [@bib38]) which, within yeast cells, localize to MCSs where they facilitate the intermembrane transfer of sterol lipids via VaST domains ([Figure 1A](#fig1){ref-type="fig"}) ([@bib18]; [@bib21]; [@bib38]). In yeast, Ltc1/Lam6 localizes to ER-mitochondria and ER-lysosome/vacuole contacts via physical interactions with the protein partners, Tom70/71 and Vac8, respectively ([@bib21]; [@bib38]). Ltc3/Lam4 and Ltc4/Ysp2 paralogs are localized to ER-PM MCSs, where they have been implicated in the retrograde transport of sterols from the PM to the ER and in regulation of PM TORC2 activity to coordinate sterol and sphingolipid homeostasis ([@bib21]; [@bib39]). Here we examined the functions of the uncharacterized human Ltc/Lam protein orthologs, GRAMD1a and GRAMD2a. Our analysis indicates that GRAMD1a and GRAMD2a are ER-PM tethers that mark and define functionally distinct regions of the PM.

![Defining a new family of human ER MCS proteins.\
(**A**) Human proteins GRAMD1a-c and GRAMD2a and b are members of a protein family with similarity to the yeast Ltc1/Lam proteins, which all possess an unstructured N-terminus, a GRAM domain, and an ER-anchoring hydrophobic transmembrane domain. GRAMD1a-c contain an additional predicted sterol transport START-like VaST domain, similar to yeast family member Ltc1/Lam6. (**B**) Alignment of conserved GRAM domains from yeast and human family members. (**C--D**) Localization of GRAMD1a-eGFP (**C**) and GRAMD2a-eGFP (**D**) in COS7 mammalian cells relative to ER-marker mCherry-Sec61β and PM-marker lyn-mCherry. (**E--F**) Examination of localization of GRAMD1aΔGRAM (**E**) and GRAMD2aΔGRAM (**F**) with mCherry-Sec61β. Representative images shown from at least 17 cells that were obtained from three biological replicates. Scale bar 10 μm in full images and 5 μm in insets (the same dimensions are maintained for all subsequent figures).](elife-31019-fig1){#fig1}

Results {#s2}
=======

GRAM domain-dependent targeting of GRAMD1a and GRAMD2a to ER-PM MCSs {#s2-1}
--------------------------------------------------------------------

Yeast Ltc/Lam proteins possess a common domain structure that includes an N-terminal unstructured region, a PH-like GRAM domain, which in the context of MTMR2 binds PIP lipids; one or two START-like VASt domains, which bind and facilitate sterol transport; and a C-terminal transmembrane domain (TMD) helix, which anchors them into ER membrane ([Figure 1A](#fig1){ref-type="fig"}) ([@bib1]; [@bib2]; [@bib21]; [@bib38]). Using phylogenetic analysis and structure prediction programs, we identified the uncharacterized GRAM-domain containing proteins, GRAMD1a-c, GRAMD2, and GRAMD3 as human Ltc orthologs. Our analysis indicates that the human family is characterized by the presence of a related GRAM domain as only GRAMD1a-c share the yeast canonical domain structure ([Figure 1A and B](#fig1){ref-type="fig"}; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). GRAMD2 and GRAMD3 lack a VASt domain and only possess a related GRAM and ER-anchoring TM domain ([Figure 1A](#fig1){ref-type="fig"}). Accordingly, with permission from the HUGO Gene Nomenclature Committee, we renamed GRAMD2 and GRAMD3 as GRAMD2a and GRAMD2b, respectively.

To gain insight into function, we examined the intracellular localization of transiently expressed fluorescently labeled versions of the human Ltc/Lam orthologs in mammalian cells using spinning disk microscopy. Both GRAMD1a-eGFP and GRAMD2a-eGFP were observed in focal structures at the periphery of Cos7 cells, suggesting that, similar to previously characterized yeast Ltc3/4 (Lam4/Ysp2) proteins, they localize to ER-PM contact sites ([Figure 1C and D](#fig1){ref-type="fig"}). To test this, we examined their localization relative to an ER marker, mCherry-Sec61β, or PM marker, lyn-mCherry. Consistently, analysis of Z stack images and Z-stack reconstructions of cells indicate that peripheral GRAMD1a-eGFP and GRAMD2a-eGFP foci co-localized with ER and PM ([Figure 1C and D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B and C](#fig1s1){ref-type="fig"}; [Figure 1---video 1](#fig1video1){ref-type="video"}, [2](#fig1video2){ref-type="video"}, [3](#fig1video3){ref-type="video"}, [4](#fig1video4){ref-type="video"}). Additionally, we used total internal reflection (TIRF) microscopy, which allows selective illumination within \~100 nm of the PM, to examine cells expressing either GRAMD1a-eGFP or GRAMD2a-eGFP and both BFP-Sec61β and lyn-mCherry ([Figure 1---figure supplement 1D and E](#fig1s1){ref-type="fig"}). Line scans of individual GRAMD1a or GRAMD2a puncta revealed that GRAMD1a and GRAMD2a labeled focal structures co-localized with cortical ER coincident with the PM ([Figure 1---figure supplement 1D and E](#fig1s1){ref-type="fig"}). Thus, our cytological data indicate that GRAMD1a and GRAMD2a localize to ER-PM MCSs.

We examined the molecular basis for GRAMD1a and GRAMD2a targeting to ER-PM MCSs. Previously, it was shown that the GRAM domain of yeast Ltc1 is required for mitochondrial localization of Ltc1 ([@bib38]), suggesting that the GRAM domain is a critical determinant of MCS localization. Consistent with this model, variants of GRAMD1a and GRAMD2a lacking their GRAM domain (GRAMD1aΔGRAM-eGFP and GRAMD2aΔGRAM-eGFP, respectively) exhibited diffuse ER localization and were not observed to localize in focal structures at ER-PM MCSs ([Figure 1E and F](#fig1){ref-type="fig"}, respectively). These data indicate that GRAMD1a and GRAMD2a are targeted to the PM via their GRAM domains and further suggest that this targeting mechanism is a general feature of the family.

GRAMD1a and GRAMD2a localize to distinct ER-PM MCSs {#s2-2}
---------------------------------------------------

To further characterize GRAMD1a and GRAMD2a cortical structures, we examined their relationship to each other. In cells co-expressing both GRAMD2a-mCherry and GRAMD1a-eGFP, no co-localization of GRAMD2a and GRAMD1a labeled foci was observed as only \~8% of total GRAMD2a-eGFP fluorescence pixels overlapped with GRAMD1a-eGFP fluorescent pixels and visa versa ([Figure 2A](#fig2){ref-type="fig"}). These data suggest that GRAMD1a and GRAMD2a mark distinct ER-PM contact sites. To test this idea, we examined the relationship of GRAMD2a and GRAMD1a marked cortical foci to the localization of E-Syts2/3, which are well characterized ER-PM tethers that hetero-oligomerize and localize to ER-PM contacts via interaction with PM PI(4,5)P~2~ lipid domains ([Figure 2B and C](#fig2){ref-type="fig"}) ([@bib19]; [@bib22]). Analysis of cells expressing GRAMD2a-eGFP and either mCherry-E-Syt2 or E-Syt3-mCherry revealed that a majority of the GRAMD2a-eGFP fluorescence signal co-localized with mCherry-E-Syt2 and E-Syt3-mCherry signals (75.9 ± 2.5% and 85.7 ± 3.3% respectively; [Figure 2B and D](#fig2){ref-type="fig"}). Consistently, line-scan analysis indicated that GRAMD2a-labeled foci were co-localized with E-Syt3-labeled regions and also with a significant fraction of E-Syt2-lableled regions at the cell cortex ([Figure 2B](#fig2){ref-type="fig"}, bottom panel). Additionally, TIRF imaging of cells expressing ER marker BFP-Sec61β with GRAMD2a-eGFP and either mCherry-E-Syt2 or E-Syt3-mCherry demonstrated that co-localized regions of GRAMD2a-eGFP with either mCherry-E-Syt2 and E-Syt3-mCherry corresponded to regions of cortical ER at the cell periphery, consistent with a shared localization at ER-PM contacts ([Figure 2---figure supplement 1A and B](#fig2s1){ref-type="fig"}). Although GRAMD2a extensively co-localized with E-Syt2 and E-Syt3 at ER-PM MCSs, a similar GRAMD2a-eGFP punctate localization pattern at cortical ER in both wildtype and E-Syt1/2/3 triple knock out HeLa cells was observed ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). These data indicate that GRAMD2a is targeted to ER-PM MCSs independent of E-Syts. In contrast to GRAMD2a, GRAMD1a-eGFP fluorescence was not significantly co-localized with either mCherry-E-Syt2 or E-Syt3-mCherry fluorescence at the cell cortex (8.9 ± 1.8% and 8.9 ± 1.0% respectively and [Figure 2C and D](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1D and E](#fig2s1){ref-type="fig"}). Together our data demonstrate that GRAMD2a and GRAMD1a localize to and distinguish distinct ER-PM MCSs.

![GRAMD2a and GRAMD1a mark distinct ER-PM contact sites.\
(**A**) Analysis of the relative localization of GRAMD1a-eGFP and GRAMD2a-mCherry in Cos7 cells. Two sample cells are shown. Bottom panel is quantification of the amount of overlapping total fluorescence signal pixels from GRAMD1a-eGFP and GRAMD2a-mCherry. Representative images of two different cells, that were imaged on two different days shown. 14 cells imaged and analyzed from three biological replicates. (**B--C**) Localization of GRAMD2a-eGFP (**B**) or GRAMD1a-eGFP (**D**) relative to mCherry-labeled ER-PM tethers E-Syt2 or E-Syt3 in Cos7 cells. Bottom panels are line scan analysis of individual GRAMD2a-eGFP (**B**) or GRAMD1a-eGFP (**C**) foci. Y-axis of line scans are arbitrary fluorescence units. (**D**) Quantification of co-localization of GRAMD2a or GRAMD1a with E-Syt2 and E-Syt3 as % of total fluorescence pixels of GRAMD1a or GRAMD2a (top panel) or ESyt2 or ESyt3 (bottom panel). Standard Error shown, \*p\<10^−2^ from two-tailed t-test. Specifically, GRAMD2a with E-Syt2 compared to GRAMD1a with E-Syt2, p=8.97 × 10^−12^; GRAMD2a with E-Syt3 compared to GRAMD1a with E-Syt3, p=3.40 × 10^−17^; E-Syt2 with GRAMD2a compared to E-Syt2 with GRAMD1a, p=9.56 × 10^−7^; E-Syt3 with GRAMD2a compared to E-Syt3 with GRAMD1a, p=3.14 × 10^−13^. Representative images shown from at least 16 cells that were obtained from three biological replicates. Pixel co-localization analysis was performed on all cells.\
10.7554/eLife.31019.010Figure 2---source data 1.[Figure 2D](#fig2){ref-type="fig"} Co-localization analysis: Top table is pixel overlap of GRAMD2a and GRAMD1a with E-Syt2 and E-Syt3; standard Error shown.Bottom table is corresponding two-tailed t-test values.](elife-31019-fig2){#fig2}

Localization of GRAMD2a and GRAMD1a to distinct ER-PM domains suggests that they possess distinct physiological functions. To infer potential roles of these genes, we performed gene set enrichment analysis (GSEA) using their expression levels as input phenotypes to find gene sets that co-expressed with GRAMD genes ([@bib52]) in transcriptome data from liver samples of human ([@bib47]) and mouse populations ([@bib58]). Consistent with their different intracellular localizations, we found that *GRAMD1A* and *GRAMD2A* transcripts exhibited quite diverse correlated pathways ([Figure 3A](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}), suggesting their distinct functions. Specifically, *GRAMD2a/Gramd2a* exhibited robust positive correlations with genes involved in lipid metabolism in human and mouse populations, while *GRAMD1a/Gramd1a* showed opposite correlation patterns ([Figure 3A](#fig3){ref-type="fig"}, green gene-sets; [Figure 3B](#fig3){ref-type="fig"}, upper panel; [Figure 3C](#fig3){ref-type="fig"}, left panel; and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}, left panel). These observations indicate that GRAMD1a and GRAMD2a possess distinct functions in mammals in vivo, consistent with our cellular data demonstrating that they localize to distinct ER-PM contacts.

![Gene set enrichment analysis of GRAMD1a and GRAMD2a indicated distinct physiological functions.\
(**A**) Comparison of enrichment results between *GRAMD1a* and *GRAMD2a* in transcriptome data of liver samples from 193 female human individuals. Normalized enrichment score (NES) of *GRAMD1a* and *GRAMD2a* are used to compare the GO pathway enrichment of these two genes in lipid metabolism and Ca^2+^ signaling gene sets highlighted in green and blue, respectively. Dot size represents the number of genes, and transparency of the dot indicates the significance (-log~10~(nominal *p* value)) of the enrichment of the two transcripts for the gene set. (**B**) Heat-map showing the enrichment of *GRAMD1a* and *GRAMD2a* in genes involved in lipid metabolism and Ca^2+^ signaling in liver samples from human male and female individuals, as well as from males of the BXD mouse genetic reference population. (**C--D**) Enrichment plot of *GRAMD1a* and *GRAMD2a* in human liver samples from female individuals shows their distinct physiological functions in lipid metabolism (**C**) and Ca^2+^ signaling pathways (**D**). FDR, false discovery rate.](elife-31019-fig3){#fig3}

GRAMD2a targeting to PM is dependent on PI(4,5)P2 {#s2-3}
-------------------------------------------------

PI(4,5)P2 is highly enriched in ER-PM contact sites and mediates the localization of E-Syt2/3 to ER-PM MCSs ([@bib7]; [@bib13]; [@bib45]). Thus, given the co-localization of GRAMD2a with E-Syt2 and E-Syt3, we asked if GRAMD2a targets to PM MCSs in cells in a manner dependent on PIP lipids. To test this, PI(4,5)P2 was depleted from the PM by stimulating phosphoinositide-specific phospholipase C (PLC) using the muscarinic agonist oxotermorine-M (OxoM) in cells transfected with the muscarinic acetylcholine receptor (M1R) ([@bib14]; [@bib22]). We imaged cells overexpressing untagged M1R and monitored PM PI(4,5)P2 using the specific fluorescent biosensor CFP-PH-PLC~δ1~. Following addition of Oxo-M, PM associated CFP-PH-PLC~δ1~ and GRAMD2a-mCherry coordinately and significantly decreased. Following removal of Oxo-M from the media both PM associated CFP-PH-PLC~δ1~ and GRAMD2a-mCherry increased but with different kinetics; PM associated GRAMD2a-mCherry fluorescence more rapidly recovered as compared the PI(4,5)P2 selective marker, CFP-PH-PLC~δ1~ ([Figure 4A and B](#fig4){ref-type="fig"}, top panel). In contrast, GRAMD1a-mCherry fluorescence remained associated with the cortex following addition of Oxo-M, although PM-associated CFP-PH-PLC~δ1~ fluorescence decreased ([Figure 4A and B](#fig4){ref-type="fig"}, bottom panel). These observations suggest that targeting of GRAMD2a to ER-PM contacts is at least in part dependent on PI(4,5)P2, while GRAMD1a targeting is PI(4,5)P2-independent, further substantiating that GRAMD2a and GRAMD1a localize to distinct ER-PM domains in human cells.

![GRAMD2a is targeted to the PM via PI(4,5)P2.\
(**A--B**) Examination of the PI(4,5)P2-dependent behavior of PM-associated GRAMD2a-eGFP (**A**) and GRAMD1a-eGFP (**B**). PM PI(4,5)P2 was reversibly depleted by 10 s addition (middle panel) and removal (left panel) of 10 μM of the muscarinic agonist oxotremorineM (OxoM) as monitored by the PI(4,5)P2 marker CFP-PH-PLC~δ1~. Normalized intensity of fluorescent proteins used in PI(4,5)P2 depletion experiments shown in lower panels of (**A and B**). Representative images shown from at least 12 cells that were obtained from two biological replicates. Fluorescence intensity dynamics were analyzed for all cells. (**C**) Western Blot analysis of centrifugation-based liposome binding assays with recombinant His6-GRAMD2aΔTM and liposomes of different composition. Control PM-like liposomes: 85% PC: 15% PS; PM-like liposomes with PI: 85% PC: 10% PS: 5% PI or 85% PC: 15% PI; PM-like liposomes with PI(4)P: 85% PC: 14% PS: 1% PI(4)P, 85% PC: 10% PS: 5% PI(4)P, or 85% PC: 15% PI(4)P; PM-like liposomes with PI(4,5)P2: 85% PC: 14% PS: 1% PI(4,5)P2, 85% PC: 10% PS: 5% PI(4,5)P2, or 85% PC: 15% PI(4,5)P2. S and P indicate supernatant and pellet, respectively. (**D**) Quantification of liposome binding experiments, n = 4 (biological replicates), Standard Error shown.\
10.7554/eLife.31019.015Figure 4---source data 1.[Figure 4D](#fig4){ref-type="fig"} Quantification of liposome binding assays with recombinant His6-GRAMD2aΔTM: liposome assays were repeated four times; standard Error shown.](elife-31019-fig4){#fig4}

To more directly test the idea that GRAMD2a PM targeting is dependent on PI(4,5)P2, we expressed and purified the predicted GRAMD2a cytosolic domain (amino acids 1--298, 6xHis-GRAMD2aΔTMD) and performed liposome-binding assays ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). Western blotting analysis of liposome binding assays revealed that GRAMD2aΔTM significantly and specifically associated with liposomes containing either PI(4)P and PI(4,5)P2 in a concentration-dependent manner ([Figure 4C](#fig4){ref-type="fig"}), with an apparent higher selectivity for PI(4,5)P2 versus PI(4)P ([Figure 4D](#fig4){ref-type="fig"}). The ability of GRAMD2a to bind PI(4)P in addition to PI(4,5)P2 in vitro suggests that it may bind PI(4)P, a precursor of PI(4,5)P2 in the PM, in cells and thus could be the basis for the relatively rapid kinetics of PM binding of GRAMD2a after removal of Oxo-M after PIP depletion in cells as compared to the PI(4,5)P2 marker ([Figure 4A](#fig4){ref-type="fig"}) ([@bib13]). These biochemical observations are consistent with our cytological data and indicate that GRAMD2a is targeted to the PM by directly interacting with PIP lipids. Thus, with data indicating that the GRAM domain is required for PM targeting ([Figure 1D](#fig1){ref-type="fig"}), GRAMD2a functions as a ER anchored-PM tether whose PM binding is mediated via a GRAM domain--PIP-lipid interaction.

GRAMD2a pre-marks a subset of ER-PM contacts used for STIM1 recruitment {#s2-4}
-----------------------------------------------------------------------

To gain insight into the cellular function of GRAMD2a, we asked whether its over-expression affected the extent or predominance of ER-PM contacts as measured by amount of cortical ER in cells. Increasing the amount of transfected GRAMD2a-mCherry plasmid DNA increased the amount of GRAMD2a expression ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}) and resulted in a significant increase in the area of cortical ER, marked by GFP-Sec61β, which co-localized with GRAMD2a (compare [Figure 1D](#fig1){ref-type="fig"} with [Figure 5A](#fig5){ref-type="fig"}, top panel). The GRAMD2a expression-dependent cortical ER expansion was similar to that previously described for ER-PM micro-domains or plasters linked to SOCE. Indeed, expression of mCherry-STIM1, an integral ER protein that regulates SOCE in response to decreased ER Ca^2+^ levels, also resulted in the expansion of cortical ER, consistent with published data ([Figure 5A](#fig5){ref-type="fig"}, bottom panel) ([@bib32]; [@bib40]). These observations suggest that GRAMD2a marks SOCE-specific ER-PM MCSs. To test the link between GRAMD2a and Ca^2+^ signaling, we performed GSEA on *GRAMD2a* and *GRAMD1a* with calcium signaling related pathways ([@bib52]). *GRAMD2a* showed strong positive correlations with Ca^2+^ signaling pathways across human and mouse datasets, while *GRAMD1*a did not correlate consistently with Ca^2+^ signaling ([Figure 3A](#fig3){ref-type="fig"}, blue gene sets; [Figure 3B](#fig3){ref-type="fig"}, lower panel; [Figure 3C](#fig3){ref-type="fig"}, right panel; and [Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}, right panel). Indeed, regardless of the amount transfected, GRAMD1a-mCherry retained a similar cortical punctate area and distribution in cells ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}; compare [Figure 1C](#fig1){ref-type="fig"} to [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). These results suggest a unique functional role of GRAMD2a in Ca^2+^ signaling.

![GRAMD2a pre-marks ER-PM membrane contact sites used for STIM1 recruitment during SOCE.\
(**A**) Cortical ER as visualized with ER marker GFP-Sec61β in cells overexpressing GRAMD2a-mCherry (top panel) or mCherry-STIM1 (bottom panel). (**B**) Behavior of mCherry-STIM1 at resting Ca^2+^ and upon depletion of Ca^2+^ stores from the ER using SERCA inhibitor thapsigargin (TG). At T = 30 s, 1 μM TG was added. Two representative cells shown from two different experimental days. Lower panel left shows sample graph of total fluorescence of GRAMD2a-eGFP and mCherry-STIM1 throughout duration of experiment for a sample cell. (**C**) Zoomed-in images and line scans of individual GRAMD2a fluorescent puncta and associated fluorescence for duration of the TG treatment. Left and right panels are examples of puncta from two different cells. Y-axis of line scans are arbitrary fluorescence units. Scale bar is 2 μm. (**D**) Inset cropped from top cell in (**B**). showing COS7 cell expressing GRAMD2a-eGFP, mCherry-STIM1, and BFP-Sec61β at T300s of the TG-stimulated Ca^2+^ depletion. Corresponding zoomed-in images and line-scans are shown in the bottom panel. Representative images shown from at least 19 cells that were obtained from three biological replicates.\
10.7554/eLife.31019.018Figure 5---source data 1.Quantification of the percentage of co-localized total fluorescent pixels of GRAMD2a-GFP with mCherry-STIM1 or mCherry-STIM1 with GRAMD2a-GFP as a function of time after TG addition.1 μM TG is added at T = 30 s. Standard Error shown. Analysis was performed on n = 12 cells from three independent experiments.\
10.7554/eLife.31019.019Figure 5---source data 2.[Figure 5B](#fig5){ref-type="fig"} representative line graph: Total pixels of GRAMD2a-eGFP and mCherry-STIM1 fluorescence during TG-treatment experiments (1 μM TG is added at T = 30 s) for sample cell.Quantification of 12 cells shown in [Figure 5---source data 1](#fig5){ref-type="fig"}. [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"} *Bar Graph:* Top table is pixel overlap of GRAMD2a and GRAMD1a with STIM1; standard Error shown. Bottom table is corresponding two-tailed t-test values.](elife-31019-fig5){#fig5}

To directly test whether GRAMD2a is spatially linked to SOCE, we examined whether it co-localized with STIM1 upon ER Ca^2+^ store depletion mediated by thapsigargin (TG), a non-competitive inhibitor of the sarcolemma ER Ca^2+^ ATPase ([@bib22]). We implemented a prototypic Ca2+ add back experiment to monitor the SOCE response in which TG-induces Ca2+ release from internal stores and consequent Ca2+ influx across the PM ([@bib8]). As previously described, in the absence of TG, mCherry-STIM1 was diffusely distributed throughout the ER ([@bib23]). Upon TG addition, mCherry-STIM1 rapidly re-distributed to discrete regions marked by GRAMD2a-eGFP at the cell cortex, which, based on previous observations, represent ER-PM contact sites ([Figure 5B](#fig5){ref-type="fig"}, top panel two panels, and [Figure 5---video 1](#fig5video1){ref-type="video"} and [2](#fig5video2){ref-type="video"}) ([@bib32]; [@bib59]). Consistently, after TG treatment total cortical fluorescence of mCherry-STIM1 increased significantly whereas the fluorescence intensity of cortical GRAMD2a-eGFP remained constant ([Figure 5B](#fig5){ref-type="fig"}, lower panel). To assess whether STIM1 and GRAMD2a co-localized at the cell cortex, we performed line scans of fluorescent intensity across GRAMD2a-eGFP foci before and after addition of TG. As expected, in the absence of TG, line scans indicated no significant co-localization of mCherry-STIM1 fluorescence with cortical GRAMD2a-eGFP foci ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}). Initially after TG addition, line scans indicated significant co-localization of mCherry-STIM1 fluorescence with GRAMD2a foci ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}, T50-T150) and, subsequently, regions of mCherry-STIM1 cortical fluorescence resolved from, but remained spatially linked to GRAMD2a-eGFP foci ([Figure 5C](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1C](#fig5s1){ref-type="fig"}, T150-T250). Consistent with our qualitative line scan analysis, the percentage of overlapping fluorescence pixels of GRAMD2a-eGFP with mCherry-STIM1 significantly increased following TG addition ([Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). The percentage of overlapping fluorescence pixels of mCherry-STIM1 with GRAMD2a-eGFP initially increased following TG addition, but as more mCherry-STIM1 translocated to the PM, the percentage of overlapping mCherry-fluorescence pixels of mCherry-STIM1 with GRAMD2a-eGFP decreased ([Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}). Although areas of STIM1 and GRAMD2a fluorescence spatially resolved at later time points of TG treatment, line scan analysis the ER using ER marker BFP-Sec61β revealed that STIM1 and GRAMD2a remained co-localized to a shared ER-PM contact site ([Figure 5D](#fig5){ref-type="fig"}). In contrast to GRAMD2a, STIM1 did not significantly co-localize with cortical GRAMD1a foci following TG treatment ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}). Thus, our observations further support the conclusion that GRAMD1a and GRAMD2a define distinct ER-PM contacts and indicate that GRAMD2a functions as a tether that pre-marks ER-PM contact sites specialized for STIM1 recruitment and SOCE.

Depletion of Ca^2+^ in the ER triggers the re-localization of STIM1 to the PM via an interaction of its C-terminal polybasic tail with PM PI(4,5)P2 ([@bib32]; [@bib57]). To further test whether GRAMD2a pre-marks MCSs destined for SOCE, we examined the behavior of a STIM1 mutant lacking the C-terminal PI(4,5)P2 targeting domain (STIM1ΔK) ([@bib60]). TG-induced translocation of STIM1ΔK to the PM has been reported to be strictly dependent on Orai1 overexpression ([@bib32]; [@bib41]). We examined TG-induced STIM1ΔK behavior in HeLa and COS7 cells and observed STIM1ΔK translocation to the PM is cell type dependent, where TG-induced translocation of STIM1ΔK is observed in COS7 cells and not observed in HeLa cells ([Figure 6A](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). In COS7 cells, in contrast to wild type STIM1, the localization of STIM1ΔK did not significantly overlap at any time with GRAMD2a-eGFP-marked cortical regions ([Figure 6A and B](#fig6){ref-type="fig"}). This observation indicates that STIM1ΔK is defective for targeting to PI(4,5)P2-enriched ER-PM MCSs marked by GRAMD2a. Indeed, our analysis indicates that STIM1ΔK possessed no specificity as it co-localized to approximately the same extent to GRAMD1a-marked cortical regions ([Figure 6B and C](#fig6){ref-type="fig"}). Thus our data are consistent with GRAMD2a as a PI(4,5)P2-dependent ER-PM tether that pre-marks specific ER-PM MCSs utilized for SOCE.

![STIM1ΔK is defective for targeting to PI(4,5)P2-enriched ER-PM contact sites marked by GRAMD2a.\
(**A--C**) Fluorescence images of Cos7 cells expressing mCherry-STIM1ΔK, a PI(4,5)P2-insensitive mutant, and either (**A**) GRAMD2a-eGFP or (**C**) GRAMD1a-eGFP before and after TG treatment along with (**B**) quantification of co-localization. Standard Error shown, \*p\<10^−2^ and **^--^** p\>10^−2^ from two-tailed t-test. Specifically, GRAMD2a with STIM1 compared to GRAMD2a with STIM1ΔK, p=4.47 × 10^−12^; GRAMD1a with STIM1 compared to GRAMD1a with STIM1ΔK, p=2.70 × 10^−2^; STIM1 with GRAMD2a compared to STIM1 with GRAMD1a, p=5.00 × 10^−6^; STIM1ΔK with GRAMD2a compared to STIM1ΔK with GRAMD1a, p=3.64 × 10^−1^. Representative images shown from at least 14 cells that were obtained from three biological replicates. Pixel co-localization analysis was performed on all cells.\
10.7554/eLife.31019.024Figure 6---source data 1.[Figure 5B](#fig5){ref-type="fig"} Bar Graph: Top table is pixel overlap of GRAMD2a and GRAMD1a with STIM1 and STIM1ΔK; standard Error shown.Bottom table is corresponding two-tailed t-test values.](elife-31019-fig6){#fig6}

GRAMD2a is required for normal PM STIM1 recruitment {#s2-5}
---------------------------------------------------

Given that GRAMD2a pre-marks sites of STIM1 localization at ER-PM contacts, we asked if it was required for normal STIM1 recruitment to ER-PM contacts during SOCE. We generated a GRAMD2a knock-out (KO) U2OS cell line using CRISPR genome editing ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}) and examined the kinetics of STIM1 recruitment the cortical ER ([Figure 7A](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). In GRAMD2a KO cells, the kinetics and degree of mCherry-STIM1 accumulation at the cell cortex was significantly reduced as compared to control cells following TG treatment ([Figure 7A](#fig7){ref-type="fig"}). The defect observed in STIM1 translocation to the PM in GRAMD2a KO cells was fully complimented by transiently expressing GRAMD2a-eGFP in GRAMD2a KO cells, indicating that the defect was a consequence of loss of GRAMD2a function and that GRAMD2a-eGFP is functional ([Figure 7A](#fig7){ref-type="fig"}). In addition, although the number of mCherry-STIM1 cortical puncta was not significantly different between control and GRAMD2a KO cells, the average area of mCherry-STIM1 cortical puncta was 2-fold lower in GRAMD2a KO cells as compared to control cells ([Figure 7---figure supplement 1B and C](#fig7s1){ref-type="fig"}). Decreased STIM1 puncta size in GRAMD2a KO cells was not a consequence of decreased expression of endogenous STIM1 protein ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}) or differences in the expression level of transfected mCherry-STIM1 protein in wild type and GRAMD2a KO cells as assessed by Western Blot analysis ([Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}, left panel). These data suggest that GRAMD2a functions in the organization of the subset of ER-PM MCSs dedicated to SOCE.

![GRAMD2a organizes ER-PM domains that selectively function in calcium homeostasis.\
(**A**) Kinetics and intensity of mCherry-STIM1 recruitment to PM before, during, and after 1 uM TG treatment in wildtype U2OS cells, GRAMD2a knock out (KO) cells, and GRAMD2a KO with GRAMD2a-eGFP transiently transfected. Standard Error is shown, p\<0.05 between t = 200 and t-600. (**B**) Cytosolic Ca2+ measurement using ratiomentric dye, Fura-PE3 AM during a Ca2+ addback experiment with wild type U2OS cells and GRAMD2a KO cells. Cells were pre-loaded with 2.5 uM Fura-PE3 AM in 0 mM Ca2+ Ringers and ER stores were loaded in 2 mM Ca2+ Ringers for 4 min prior to recording. Fluorescence was continuously recorded as cells were incubated in the following solutions: (1) Baseline was established in 2 mM Ca2+ ringers for 40 s, (2) cells were washed with 0 mM Ca2+/2 mM EGTA Ringers for 100 s, 3) ER stores were emptied using 4 uM TG in 0 mM Ca2+/2 mM EGTA Ringers for 460 s, 4) cells were returned to with 0 mM Ca2+/2 mM EGTA Ringers for 100 s, (5) cells were washed in 2 mM Ca2+ ringers to observe SOCE across the PM. Comparison of the cytosolic Ca2+ measurements (represented as Fura-PE3 Am ratio) are shown over time. Black trace represented control or wild type U2OS cells; red trace represents GRAMD2a KO U2OS cells. Standard Error is shown, differences between wild type and GRAMD2a traces were not statistically significant as determined using student t-test. nine wild type dishes and 8 GRAMD2a KO dishes were imaged over 2 days. 20--50 cells per dish were imaged. (**C**) Localization of mCherry-E-Syt2 (left panel) or E-Syt3-mCherry (right panel) in wild type U2OS and GRAMD2a KO cells. (**D**) Behavior of mCherry-E-Syt1 at resting Ca^2+^ and upon TG-induced ER Ca^2+^ depletion. At T = 30 s, 1 μM TG was added. Top panels show mCherry-E-Syt1 dynamics in wild type U2OS cells and bottom panels show mCherry-E-Syt1 dynamics in GRAMD2a KO cells. For STIM1 and E-Syt1/2/3 experiments, fluorescence intensity dynamics were analyzed for at least 12 cells, where were imaged in biological duplicate.](elife-31019-fig7){#fig7}

Loss of GRAMD2a does not affect SOCE, but E-Syt1 localization is significantly altered {#s2-6}
--------------------------------------------------------------------------------------

Given that loss of GRAMD2a significantly alters STIM1 recruitment to the PM during SOCE, we asked whether Ca2+ homeostasis was also affected in GRAMD2a KO cells during TG-induced SOCE. We examined cytosolic Ca2+ in GRAMD2a KO and control cells using the fluorescent ratiometric Ca2+-indicator dye Fura-PE3 AM, a leakage-resistant version of Fura-2 ([@bib8]; [@bib9]). SOCE was interrogated using the standard Ca2+ add back experiment ([Figure 7B](#fig7){ref-type="fig"}). As previously reported, wild type U2OS cells exhibited a stereotypical SOCE Ca2+ response similar to HeLa and HEK293 cells: upon TG-mediated depletion of ER Ca2+ stores, cytosolic Ca2+ increased above the baseline from Ca2+ released from internal stores and, following the addition of 2 mM Ca2+, increased above the baseline from extracellular Ca2+ influx across the PM ([Figure 7B](#fig7){ref-type="fig"}, black tracing) ([@bib8]; [@bib9]; [@bib29]). Comparison of the cytosolic Ca2+ measurements between wild type and GRAMD2a KO cells using Fura-PE3 AM indicated that there was no significant difference in the SOCE response ([Figure 7B](#fig7){ref-type="fig"}, compare black versus red tracings, respectively).

We explored whether additional and/or compensatory changes occurred in GRAMD2a cells by characterizing additional features of the PM in GRAMD2a KO cells. Cortical ER area was not significantly different in wildtype and GRAMD2a KO cells as assessed using TIRF microscopy, indicating that although GRAMD2a is a ER-PM tether, additional ER-PM tethers such as E-Syts, likely function redundantly to maintain ER-PM contacts ([Figure 7---figure supplement 2A](#fig7s2){ref-type="fig"}). Given that GRAMD2a binds PI(4)P and PI(4,5)P2, we examined PM PI(4,5)P2 lipids utilizing YFP-PH-PLC~δ1~. Line scans and quantification of relative YFP-PH-PLC~δ1~ intensity at the PM indicated that there were no apparent differences between wild type and GRAMD2a KO cells ([Figure 7---figure supplement 2B](#fig7s2){ref-type="fig"}), indicating that loss of GRAMD2a does not grossly alter PM PI(4,5)P2. We also examined whether loss of GRAMD2a affected PM cholesterol as alterations in PM cholesterol have significant effects on plasma membrane composition, architecture and function ([@bib10]). To examine cholesterol distribution in cells, we utilized the cholesterol biosensor mCherry-D4H ([@bib34]), which binds cholesterol in the cytosolic leaflet of the PM and organelles and observed similar localization patterns in wild type and GRAMD2a KO cells ([Figure 7---figure supplement 2C](#fig7s2){ref-type="fig"}). In addition, we examined the distribution of Caveolin-1 (Cav1), an essential component of caveolae, which specifically binds PM cholesterol, and observed that Cav1-GFP localization was also similar in wild type and GRAMD2a KO cells ([Figure 7---figure supplement 2D](#fig7s2){ref-type="fig"}) ([@bib54]). Finally, we examined the steady state localization of the E-Syt ER-PM tethers. Steady-state localization of constitutive E-Syt ER-PM tethers, mCherry-E-Syt2 and mCherry-E-Syt3, was not apparently different between wild type and GRAMD2a KO cells ([Figure 7C](#fig7){ref-type="fig"}). In comparison, the localization of the Ca2+-dependent ER-PM E-Syt tether, E-Syt1, was significantly altered in GRAMD2a KO cells ([Figure 7D](#fig7){ref-type="fig"}) ([@bib6]; [@bib22]; [@bib28]). Specifically, in wild type U2OS cells, as previously reported, in nominally zero external Ca2+, mCherry-E-Syt1 localized diffusely in the ER and upon TG-induced SOCE localized to punctate structures at ER-PM contacts ([Figure 7D](#fig7){ref-type="fig"}, top panel, and [Figure 7---figure supplement 3A](#fig7s3){ref-type="fig"}, left panel) ([@bib6]; [@bib28]). In contrast, in GRAMD2a KO cells in nominally zero external Ca2+, mCherry-E-Syt1 was constitutively localized at ER-PM contacts and this distribution pattern was not altered by TG-treatment ([Figure 7D](#fig7){ref-type="fig"}, bottom panel, and [Figure 7---figure supplement 3A](#fig7s3){ref-type="fig"}, right panel). Western Blot analysis indicated that mCherry-E-Syt1 protein levels were comparable in wild type and GRAMD2a KO cells ([Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}, right panel), indicating this localization difference was not a consequence of different expression levels of E-Syt1 in these cells. The punctate localization pattern of mCherry-E-Syt1 in GRAMD2a KO cells was abolished upon extracellular Ca2+ depletion and chelation with EGTA and mCherry-E-Syt1 was localized throughout the ER, indicating that E-Syt1 localization ER-PM contacts in GRAMD2a KO was dependent on cytosolic Ca2+ ([Figure 7---figure supplement 3B](#fig7s3){ref-type="fig"}). This observation suggests the possibility that the constitutive localization of E-Syt1 at ER-PM contacts in GRAMD2a KO cells is a consequence of elevated cytosolic Ca2+ relative to wild type cells. Together with the defect in STIM1 translocation, these observations indicate that loss of GRAMD2a results in a more pleiotropic defect in the organization of ER-PM contacts in cells.

Discussion {#s3}
==========

Our results identify GRAMD1a and GRAMD2a as a new class of ER-PM tethers in mammalian cells. GRAMD2a is a simple GRAM domain tether that is targeted to the PM via interaction of its GRAM PH-like domain with PIP lipid determinants -- a mechanism shared by a majority of ER-PM tethers ([Figure 8](#fig8){ref-type="fig"}) ([@bib11]; [@bib26]; [@bib43]; [@bib50]). In contrast, GRAMD1a, a tether containing both GRAM and VaST domains, interacts with the PM in a PIP lipid independent manner, raising the possibility that it may have a proteinaceous PM partner and/or be targeted via another PM lipid species, such as cholesterol given the characterized role of the VaST domain in sterol transport ([@bib21]; [@bib39]; [@bib55]; [@bib27]). In this context, the localization of GRAMD1a to ER-PM contacts is cell-type specific; GRAMD1a-marked ER-PM contacts are present in Cos7, Hek293, HeLa, and Arpe19, cells but absent in U2OS or HCT116 cells ([Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}).

![Model of GRAMD2a function.\
GRAMD2a is a constitutive PI(4,5)P2-dependent ER-PM tether that localizes to a subset of E-Syt2/3 contacts. GRAMD1a marks distinct ER-PM contacts in a PI(4,5)P2-independent manner. GRAMD2a pre-marks ER-PM contacts destined for SOCE and facilitates, STIM1 recruitment during SOCE.](elife-31019-fig8){#fig8}

Our results conclusively demonstrate the co-existence of physically distinct ER-PM domains at steady state in mammalian cells, uniquely defined by GRAMD1a or GRAMD2a. Consistent with their distinct composition and spatial resolution, GRAMD1a and GRAMD2a-marked ER-PM contact sites also play discrete functional roles at both the cellular and physiological level. The cellular function of GRAMD1a ER-PM contacts sites is currently not known, but the presence of yeast Ltc/Lam-related VaST domain, which mediates inter-membrane sterol transport, suggests GRAMD1a, similar to the yeast Ltc3/4 homologs, may play a role in the regulation of sterol homeostasis ([@bib21]; [@bib39]).

Our data show that GRAMD2a functions as a constitutive tether that pre-marks and specifies ER-PM contact sites destined for SOCE, providing an explanation of previous work demonstrating that only a subset of E-Syt2/3-marked ER-PM contacts are utilized by STIM1 ([Figure 8](#fig8){ref-type="fig"}) ([@bib5]; [@bib22]; [@bib56]). Consistent with a role for GRAMD2a in SOCE, in its absence we observed that the kinetics and extent of STIM1 translocation to ER-PM contacts during SOCE was significantly altered. However, loss of GRAMD2a did not significantly affect the number of STIM1 puncta or the SOCE Ca2+ response in cells, emphasizing the redundancy of ER-PM tethers, such as E-Syt1/2/3 and oxysterol-binding protein (OSBP)/OSBP-related proteins in the maintenance or ER-PM contacts ([@bib45]). Although the SOCE Ca2+ response was not apparently affected in cells lacking GRAMD2a, the Ca2+-dependent ER-PM E-Syt1 tether was abnormally localized to ER-PM contacts under conditions in which the internal ER Ca2+ stores were full. Relatively small changes in basal cytosolic Ca2+ are sufficient for E-Syt1 PM recruitment, raising the possibility that loss of GRAMD2a alters cytosolic Ca2+ in a range or spatial manner not detected by Fura-2 ([@bib28]). In addition, altered E-Syt1 PM localization in GRAMD2a KO cells suggests that there is a constitutive engagement of E-Syt1's functions at the PM, which include Ca2+-dependent E-Syt1-mediated lipid transport and PI(4,5)P2 maintenance, which, in turn, likely alter cellular physiology, including Ca2+ homeostasis. This raises the possibility of a compensatory Ca2+ homeostatic mechanism at ER-PM contact sites in cells lacking GRAMD2a ([@bib3]; [@bib6]; [@bib28]).

Together with our observation that GRAMD2a pre-marks sites of SOCE, our data suggest a model in which GRAMD2a serves as a constitutive master tether at MCSs with pleiotropic functions including STIM1 recruitment and Ca2+ homeostasis ([Figure 8](#fig8){ref-type="fig"}). Consistent with this model, GSEA analysis linked GRAMD2a to a variety of calcium pathways in the cell ([Figure 3B](#fig3){ref-type="fig"}, lower panel). Mechanistically, given its domain structure and size, GRAMD2a is likely to create a tight ER-PM junction, which may uniquely be required to organize this putative domain and facilitate STIM1 recruitment, consistent with the observed preference of STIM1 for the relatively narrow junction created by E-Syt1 over E-Syt2/3 ([@bib19]). Our cytological data also indicate that upon ER Ca^2+^ depletion, GRAMD2a and STIM1 initially are co-localized at ER-PM contacts but subsequently become spatially resolved within a contact, suggesting that GRAMD2a may also play a role in the formation of distinct microdomains within ER-PM contacts during SOCE, which would represent an additional level of complexity in the biogenesis and functionality of MCSs. In the absence of GRAMD2a, we speculate that this domain is altered, resulting in compensatory changes in calcium regulatory networks ([@bib15]).

Based on our observations from yeast and mammalian cells, we speculate that members of the Ltc/GRAM superfamily are ER tethers whose partner specificity is coded by their conserved GRAM domain -- the defining family feature ([@bib38]). The shared ER localization of the Ltc/GRAM proteins in cells raises the possibility that combinatorial intermolecular interactions may occur between family members within the ER to further regulate their localizations and functions beyond ER-PM contacts within the ER-contact site network. As such, our work forms the basis for future experiments aimed at understanding the molecular machinery that regulates cross-talk and interaction between ER and other organelles in a dynamic cellular environment.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or resource          Designation                                      Source or reference                  Identifiers
  ------------------------------------------- ------------------------------------------------ ------------------------------------ --------------------------------------------------------------
  6s-His Tag monoclonal antibody              Western Blot antibody                            ThermoFisher (His.H8)                RRID:[AB_557403](https://scicrunch.org/resolver/AB_557403)

  STIM1 monoclonal antibody                   Western Blot antibody                            ThermoFisher (CDN3H4)                RRID:[AB_2197884](https://scicrunch.org/resolver/AB_2197884)

  GAPDH polyclonal antibody                   Western Blot antibody                            SigmaAldrich (G9545)                 RRID:[AB_796208](https://scicrunch.org/resolver/AB_796208)

  anti-mCherry polyclonal antibody            Western Blot antibody                            ThermoFisher (PA5-34974)             RRID:[AB_2552323](https://scicrunch.org/resolver/AB_2552323)

  Goat anti-mouse or anti-rabbit antibodies   Western Blot antibody (DyLight 800\              ThermoFisher                         
                                              and DyLight 680)                                                                      

  Oxotremorine M                              Non-selective muscarinic\                        SigmaAldrich                         
                                              acetylcholine receptor agonist                                                        

  Thapsigargin                                Non-competative SERCA inhibitor                  Invitrogen/Life-technologies         

  Fura-PE3 AM                                 Ratiometric cytosolic calcium indicator          Teflabs                              

  Lipofectamine2000                           Tissue culture transfection reagent              ThermoFisher                         

  Lipids                                      All lipids used for liposome binding assays      Avanti Lipids                        

  COS7 cells                                  Cercopithecus aethiops kidney cell line          G. Voeltz (U of Colorado, Boulder)   RRID:[CVCL_0224](https://scicrunch.org/resolver/CVCL_0224)

  U2OS cells                                  Human bone osteosarcoma epithelial cell line     G. Voeltz (U of Colorado, Boulder)   RRID:[CVCL_0042](https://scicrunch.org/resolver/CVCL_0042)

  HeLa cells                                  Homo sapiens cervix adenocarcinoma cell line     P. De Camilli (Yale U)               RRID:[CVCL_0058](https://scicrunch.org/resolver/CVCL_0058)

  ARPE19 cells                                Human retinal pigment epithelial cell line       ATCC (CRL-2302)                      RRID:[CVCL_0145](https://scicrunch.org/resolver/CVCL_0145)

  HEK293 cells                                Homo sapiens embryonic kidney cell line          E. J. Dickson collection             RRID:[CVCL_0045](https://scicrunch.org/resolver/CVCL_0045)

  Fiji (ImageJ) software                      Software used to analyse all microscopy images   ImageJ                               RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)

  ImageStudioLight                            Software used to analyse all Western Blots       LI-COR BioSciences                   RRID:[SCR_014211](https://scicrunch.org/resolver/SCR_014211)

  Mega7                                       Software used to analyse all Western Blots       MEGA Software                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Antibodies and chemicals {#s4-1}
------------------------

6x-His Tag monoclonal primary antibody (His.H8, ThermoFisher), STIM1 monoclonal antibody (CDN3H4, ThermoFisher), mCherry polyclonal antibody (PA5-34974, ThermoFisher), GAPDH polyclonal antibody (G9545, SigmaAldrich), goat anti-mouse and anti-rabbit secondary antibodies DyLight 800 and DyLight 680 (ThermoFisher) were used for western blots. OxotremorineM (Sigma-Aldrich), thapsigargin (Invitrogen/Life-technologies), isopropylthio-β-galactoside (ThermoFisher), Fura-PE3 AM (Teflabs), Protease Inhibitor (PI) Cocktail Set 1 (Calbiochem/EMD Millipore), 0.01% poly-L-lysine solution (Sigma), Ni-IDA resin (Protino/Macherey-Nagel), Lipofectamine2000 (ThermoFisher). Following concentration of chemicals are used in all the experiments unless noted: oxotremorineM, 10 μM; thapsigargin, 1 μM; isopropylthio-β-galactoside, 0.5 μM. All lipids were obtained from Avanti Polar Lipids; 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 850375C; 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 16:0-18:1 (POPS), 840034C; 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS), 840035; L-α-phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), 840046; L-a-phosphatidylinositol-4-phosphate (PI(4)P), 840045X; L-a-phosphatidylinositol (PI), 84042C.

Cell culture and transfection {#s4-2}
-----------------------------

COS7, U2OS, ARPE19, HEK293 and HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (P/S) at 37°C and 5% CO~2~. Transfection of plasmids was carried out with Lipofectamine2000 (ThermoFisher) according to manufacturer's instructions. Wild-type as well as genome-edited U2OS cell lines were verified as free of mycoplasma contamination by a PCR-based method. All cell-based experiments were repeated at least two times.

Fluorescence microscopy {#s4-3}
-----------------------

For imaging experiments, cells were plated at low density (120,000 to 150,000 cells/plate or cover-slip) on 35 mm poly-D-lysine glass bottom dishes (MatTek Corp) or on 25 mm circular glass coverslips (FisherScientific) that were coated with 0.01% poly-L-lysine solution (Sigma). Live cell imaging was carried out one day after transfection using one of the following three microscopes: (1) confocal microscopy was performed using spinning disc module of a Marianas SDC Real-Time 3D Confocal-TIRF microscope (Intelligent Imaging Innovations, 3i) fit with a Yokogawa spinning disk head, a 100 × 1.46 NA objective (Olympus) and EMCCD camera, controlled by Slidebook software (Intelligent Imaging Innovations, 3i); (2) confocal microscopy for all of the OxoM and some TG treatment experiments were performed using Zeiss 880 laser-scanning microscope, equipped with an Airyscan detector; a 63x oil immersion lens, controlled by Zen software (Zeiss); (3) total internal reflection fluorescence (TIRF) microscopy was performed on a Nikon motorized TIRF rig setup built around a Nikon TiE microscope equipped with perfect focus and 100x/1.49 CFI Apo TIRF oil immersion objectives, controlled by Elements software (Nikon). Unless otherwise stated, before imaging cells were transferred to Ringers solution containing 160 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM Hepes, and 8 mM glucose, pH 7.4 (NaOH). Unless otherwise stated, GRAMD1a-GFP and GRAMD2a-GFP are transfected at 100 ng per 35 mm MatTek dish. In overexpression experiments ([Figure 5A](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}), 1 μg of both GRAMD1a-GFP and GRAMD2a-GFP was transfected.

GRAMD2a purification {#s4-4}
--------------------

Soluble GRAMD2 without the C-terminal transmembrane domain (GRAMD2ΔTM: 1--298 aa) was cloned into pET15b vector. His~6~-GRAMD2ΔTM was purified from BL21 *E. coli* containing RIPL plasmid (encoding nonabundant tRNAs). All expression and purification were performed with cultures were grown to at 37°C. Cultures were grown to OD600 0.7 and expression was induced with 0.5 mM IPTG for 2 hr. Cells were harvested routinely by centrifugation, resuspended in a buffer (50 mM Hepes, pH 8, 500 mM NaCl, 350 µg/ml PMSF, 1x PI cocktail, 2 mM BME) and lysed in a microfluidizer, upon which Triton X-100 was added to 0.1%. Insoluble proteins and debris were removed by centrifugation at 35,000 rpm in a Beckman 45Ti rotor for 45 min. Column packed with Ni-IDA resin, which was loaded onto a BioRad FPLC, was used to purify His~6~-GRAMD2ΔTM. Peak fractions were collected, pooled and dialyzed into storage buffer. Recombinant protein stored in 30 uL aliquots at −80°C. Additional buffers used: wash buffer -- 50 mM Hepes, pH 8, 500 mM NaCl, 1x PI cocktail, 2 mM BME, 0.1% Mega-8, 5 mM Imidazole; elution buffer -- 50 mM Hepes, pH 8, 250 mM NaCl, 1x PI cocktail, 2 mM BME, 0.1% Mega-8, 250 mM Imidazole; dialysis buffer: 50 mM Hepes, pH 8, 150 mM NaCl, 2 mM BME; storage buffer -- 50 mM Hepes, pH 8, 150 mM NaCl, 2 mM BME, 10% glycerol.

Liposome binding assays {#s4-5}
-----------------------

Lipids were obtained from Avanti Polar Lipids in chloroform or methanol. Liposomes were prepared as described in [@bib12]. In short, liposomes were mixed in the appropriate ratios and dried under nitrogen gas. The dried lipids were placed under vacuum for at least 1 hr, and hydrated in 20 nM Tris-HCl, pH 8, 150 mM NaCl for 20 min using a sonicating bath. Hydrated liposomes were extruded through a 1 μm nanopore membrane (GE Healthcare) a minimum of 15 times. Compositions of liposomes used in this study were as follows. Control PM-like liposomes: 85% PC: 15% PS; PM-like liposomes with PI: 85% PC: 10% PS: 5% PI or 85% PC: 15% PI; PM-like liposomes with PI(4)P: 85% PC: 14% PS: 1% PI(4)P, 85% PC: 10% PS: 5% PI(4)P, or 85% PC: 15% PI(4)P; PM-like liposomes with PI(4,5)P2: 85% PC: 14% PS: 1% PI(4,5)P2, 85% PC: 10% PS: 5% PI(4,5)P2, or 85% PC: 15% PI(4,5)P2.

Liposomes (final concentration 1.2 mg/mL) were incubated with 1.2 μM recombinant GRAMD2ΔTM at room temperature for 90 min. Following incubation, liposomes and recombinant GRAMD2ΔTM were centrifuged in a TLA-100 rotor in Beckman TLA-100 Ultracentrifuge at 40,000 *g* for 30 min at 4°C. Supernatant and pellet are separated and pellet was resuspended in equivalent volume of 20 mM Tris-HCl, pH 8, 150 mM NaCl as suppernatent. 6x Laemmli was added to pellet and suppernatent and western blots were performed with samples. Anti-His6 antibody was used to detect recombinant His6-GRAMD2ΔTM. Western blots were scanned on LI-COR Odyssey Imager.

Phylogenetic analysis and sequence alignment {#s4-6}
--------------------------------------------

Phylogenetic analysis and structure prediction programs reveal that Ltc1/2/3/4 (Lam6/5/4/2) and GRAMD1a/b/c as well as GRAMD2/3 are orthologs of a family of proteins that is anchored via the presence of the GRAM domain (Figure S1A). MEGA7 software ([@bib30]) was used to create a Maximum Likelihood phylogenetic tree of proteins possessing GRAM domains and PH domains from *Homo sapiens*, *Saccharomyces cerevisiae*, and *Drosophila melanogaster*. A phylogenetic tree that was bootstrapped 1000 times indicated that the GRAMD domains from *H. sapian* proteins GRAMD1a/b/c, GRAMD2, and GRAMD3 share a common ancestor with their *S. cerevisiae* protein orthologs Ltc1/2/3/4 (Lam6/5/4/2). GRAMD4, on the other hand, is not evolutionarily related to GRAMD1a/b/c, GRAMD2, or GRAMD3. MUSCLE alignment ([@bib16]) of GRAM domains from Ltc1/2/3/4 (Lam6/5/4/2) and GRAMD1a/b/c as well as GRAMD2/3 reveals a high degree of conservation among these nine proteins ([Figure 1B](#fig1){ref-type="fig"}). Sequences used for GRAM domain homology alignment were the following:

Q96CP6 GRAMD1a 91--158

Q3KR37 GRAMD1b 96--163

Q8IYS0 GRAMD1c 69--136

Q8IUY3 GRAMD2a/GRAMD2 72--139

Q96HH9 GRAMD2b/GRAMD3 110--177

Q08001 LTC1/LAM6 164--231

P43560 LTC2/LAM5 198--265

P38800 LTC3/LAM4 548--617

Q06681 LTC4/LAM2 647--716

ER Ca^2+^ depletion and PI(4,5)P2 depletion experiments {#s4-7}
-------------------------------------------------------

To monitor store-operated calcium entry (SOCE), cells were cultured and transfected on 35 mm MatTek poly-D-lysine coated dishes (MatTek Corporation) or on 25 mm coverslips (ThermoFisher) pre-coated with poly-L-lysine (Invitrogen). If cells that were plated on 25 mm cover slips were placed into a perfusion chamber (QCM-825-IPB, Quorum Technologies Inc, Ontario) where cells were incubated in a series of buffers. On day of imaging cells were washed twice and incubated with Ca^2+^-free Ringer's solution (160 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 10 mM HEPES, 8 mM glucose, pH 7.4 (NaOH) for up to 30 min before imaging. 4 min prior to imaging ER stores were preloaded by incubating the cells in Ringer's solution with 2 mM Ca2+. All experiments were performed at 37°C unless otherwise noted.

### STIM1 ([Figure 5](#fig5){ref-type="fig"}), STIM1ΔK ([Figure 6](#fig6){ref-type="fig"}), and E-Syt1 ([Figure 7](#fig7){ref-type="fig"}) experiments {#s4-7-1}

Different solutions were applied to cell by bath application. Cells were incubated in a series of buffers during which cells were imaged every 5 s: (1) after ER Ca2+ stores were preloaded in 2 mM Ca2+ Ringer's solution, cells were washed twice and Ca^2+^-free Ringer's solution was added to the cells; (2) 1 μM thapsigargin (TG) was added in 0 mM Ca^2+^ Ringer's solution 30 s after start of imaging; (3) 2 mM Ca^2+^ Ringer's solution was added 100 s after TG treatment. Imaging was performed using the Marianas SDC Real-Time 3D Confocal-TIRF microscope every 10 s. Excitation light was provided by 405 nm (for BFP), 488 nm (for eGFP), and 561 nm (for mCherry).

### STIM1 experiments in [Figure 7](#fig7){ref-type="fig"} {#s4-7-2}

Different solutions were applied to cells using a perfusion system. Cells were incubated in a series of buffers during which cells were imaged every 5 s: (1) 2 mM Ca^2+^-containing Ringer's solution for 100 s; (2) 0 mM Ca^2+^ Ringer's solution for 100 s; (3) 0 mM Ca^2+^ Ringer's solution with 1 μM TG for 100 s; (4) 2 mM Ca^2+^ Ringer's solution. Imaging was performed using a 63x TIRF, 1.49 N.A Olympus objective mounted on an Olympus Cell TIRF system. Excitation light was provided by 488 nm (for eGFP) and 561 nm (for mCherry).

### PI(4,5)P2 depletion experiments in [Figure 4](#fig4){ref-type="fig"} {#s4-7-3}

Different solutions were applied to cells using a perfusion system. Cells were incubated in a series of buffers during which cells were imaged every 5 s: (1) 2 mM Ca^2+^-containing Ringer's solution; (2) between t = 100 s and t = 120 s, cells were incubated Ringer's solution with 10 μM of oxotremorine; (3) 2 mM Ca^2+^-containing Ringer's solution. Cells were imaged using the Zeiss 880 laser-scanning microscope, equipped with an Airyscan detector, every 10 s. Excitation light was provided by 435 nm (for CFP) and 561 nm (for mCherry).

### Cytosolic Ca2+ experiments in [Figure 7](#fig7){ref-type="fig"} {#s4-7-4}

Cytosolic Ca2+ was measured in the U2OS cells at 32°C. Cells were loaded with 2.5 uM Fura-PE3 AM, a leakage-resistant version of Fura 2 (Teflabs), at 2 µM in nominally Ca2+-free Ringer's solution, for 45 min, followed by 45 min wash to allow de-esterification. Loading time and concentration were the minimum needed to produce acceptable signal-to-noise ratios, in order to minimize any dye-dependent Ca2+ buffering. ER stores were loaded in 2 mM Ca2+ Ringers for 4 min prior to recording fluorescence. Different solutions were applied to cells using a perfusion system: (1) 2 mM Ca^2+^-containing Ringer's solution for 40 s; (2) 0 mM Ca2+/2 mM EGTA Ringers for 100 s; (3) 0 mM Ca2+/2 mM EGTA Ringers solution with 4 μM TG for 460 s; (4) 0 mM Ca2+/2 mM EGTA Ringers solution for 100 s; (5) 2 mM Ca^2+^ Ringer's solution. Fluorescence was detected at 530 ± 20 nm FWHM with a photomultiplier, in response to alternating sequential excitation (10 Hz) at 340 and 380 nm, delivered by a Xe arc lamp through a Cairn Optoscan monochromator. In each experiment, fluorescence signals due to 340 and 380 nm from cells within a fixed size region of interest were demultiplexed and separately recorded. For analysis, the 340/380 fluorescence ratio was formed, with each λ first corrected by subtracting cell-free system background from a same-sized area.

Plasmids, strains, and cloning {#s4-8}
------------------------------

The following reagents were kind gifts: pAc-mCherry-E-Syt2 and pAc-E-Syt3-mCherry from P. De Camilli (Yale University) ([@bib22]); pcDNA3.0-HAII-M1R(dark), pYFP-PH-PLCdelta1, and pCFP-PH-PLCdelta1 from B. Hille (University of Washington) ([@bib53]) ([@bib4]); pAc-mCherry-E-Syt1 from J. Liou (University of Texas, Southwestern Medical Center) ([@bib6]); pmCherry-D4H from G. Fairn (University of Torono) ([@bib34]); plyn-mCherry, pAc-GFP-Sec61β, pAc-mCherry-Sec61β, pAc-TagBFP-Sec61β, and pEX-SP-YFP_STIM1(23--685) from G. Voeltz (University of Colorado, Boulder) ([@bib20]; [@bib33]). pAc-Cav1-GFP was purchased from Addgene (14433).

Wild type HeLa and E-Syt triple knock-out (TKO) cells were kind gifts from P. De Camilli (Yale University) ([@bib44]). HEK293 cells were taken from the collection of E. J. Dickson (author on this study). COS7 and U2OS cells lines were kind gifts from G. Voeltz (University of Colorado, Boulder). ARPE19 cells were purchased from ATCC (CRL-2302).

cDNA clones of human GRAMD1a and GRAMD2a/GRAMD2 were obtained from Origene (GRAMD1a: RC226692, GRAMD2a: RC220145) and cloned into pAcGFP1-N1 and pAcmCherry-N1 vectors. YFP was replaced with mCherry in pEX-SP-YFP_STIM1 to generate pEX-SP-mCherry_STIM1 using AgeI and NotI restriction cloning; poly-K domain of STIM1 was deleted from pEX-SP-mCherry_STIM1 using Gibson Assembly.

CRISPR genome editing {#s4-9}
---------------------

CRISPR genome editing was performed using donor vector pX330, a human codon-optimized SpCas9 and chimeric guide RNA expression plasmid, as previously described ([@bib24]). Briefly, primers coding for six different guide RNA sequences were cloned into pX330 with two overlapping primers each. U2OS cells were co-transfected with these vectors and pAc-GFP vector. Two days post transfection, individual GFP-expressing cells were FACS sorted into 96-well plates and clonal isolates were grown up. PCR-based genotyping was performed on \~80 clones and several candidate clones were identified with mutations in the GRAMD2a ORF. These clones were further analyzed by PCR-based genotyping. Guide 3 resulted in 4-nucleotide deletion in Exon 4 as selected for analysis. GRAMD2a exon 4 guide 3 (5' GTTTAAGGATGTTCCCTTGG AGG) was cloned into pX330 with two overlapping primers (Forward_Exon4_Guide 3--5\' CACCGTTTAAGGATGTTCCCTTGG and Reverse_Exon4_Guide 3--5\' AAACCCAAGGGAACATCCTTAAAC).

Statistical analysis {#s4-10}
--------------------

Co-localization analysis: ImageJ was used for analysis of co-localization for fluorescently labeled proteins. Confocal time series were exported to ImageJ, a background subtraction performed, and thresholded. Resulting images were made to look as similar as possible to the original confocal micrographs. Binary masks were created of all fluorescent pixels within thresholded images. Masks of fluorescent proteins were subtracted from each other and % pixel overlap was calculated. For example, in [Figure 2C](#fig2){ref-type="fig"}, the mask for GRAMD2a-GFP fluorescence was subtracted from the mask for Ch-E-Syt2 and visa versa, which resulted in the co-localization values presented in [Figure 2E](#fig2){ref-type="fig"}. At least 10 cells were quantified, imaged on at least two separate days (biological duplicates) are quantified. Two-tailed t-tests were performed wherever appropriate to access statistical significance. Percent fluorescence of YFP-PH-PLC~δ1~ at PM was determined using the following formula: % Fluorescence at PM = (Total integrated fluorescence density of whole cell -- integrated fluorescence density of cytosol) / (Total integrated fluorescence density of whole cell) x 100 using ImageJ plugins. At least 10 cells were quantified, imaged on at least two separate days (biological duplicates) are quantified.

Kinetic analysis: ImageJ was used for analysis of time series kinetics. Briefly, cells were background subtracted and a region of interest (ROI) was drawn around the entire TRIF footprint. Resulting time points were then exported to IGOR Pro Software or GraphPad prism for visualization and quantification of data. At least 6 cells, imaged on at least two different days were analyzed.

Measurement of STIM1 puncta size: Confocal time series were exported to ImageJ, a background subtraction performed, and thresholded. It should be noted that care was taken to ensure the resulting images were similar to the original confocal micrographs. Following this step, thresholded images were converted into binary masks and area of cluster size calculated and a frequency histogram generated using GraphPad Prism. At least 8 cells, imaged on at least two different days were analyzed.

Affinity of GRAMD2ΔTM for liposomes: Western blot scans were analyzed using Image Studio Lite software. In order to standardize quantification, a standard box was created to encompass the largest band and, subsequently, this box was used to quantify the total intensity of each band, after background subtraction. Intensity of total protein in a reaction was calculated by adding the intensity of the pellet band with the supernatant band from each reaction. % binding was calculated by dividing intensity of pellet band by intensity of total protein. Each type of liposome binding experiment was performed with all controls (reaction that contained 1 -- no liposomes, 2 -- PC/PS liposomes) at least 4 times on four different days.

Gene set enrichment analysis {#s4-11}
----------------------------

Transcript expressions from human liver of 234 male and 193 female individuals were obtained from Gene Expression Omnibus (GEO) under the accession number GSE9588 ([@bib47]). Transcript expressions from mouse livers of 41 male BXD strains were previously described ([@bib58]), and are publicly available from GEO under the accession number GSE60149. For enrichment analysis, genes were ranked based on their Pearson correlation coefficients with the expression levels of *GRAMD1A* and *GRAMD2A*, and Gene Set Enrichment Analysis (GSEA) was performed to find the enriched gene sets co-expressed with *GRAMD1A* and *GRAMD2A* ([@bib52]). Gene ontology (GO) gene sets were downloaded from the Molecular Signatures Database (MSigDB) ([@bib52]).
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"GRAM domain proteins specialize functionally distinct ER-PM contact sites in human cells\" for consideration by *eLife*. Your article has been favorably reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Randy Schekman as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Tobias Meyer (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The study by Besprozvannaya and colleagues describes the discovery of a new group of GRAM-domain containing proteins. This work is important as it shows a clear role, particularly of GRAMD2a, in controlling the localization and translocation of STIM1 proteins. The findings in the study strongly argue that GRAMD2a is part of a core machinery that sets up and regulates Ca^2+^/STIM1 signaling and potentially lipid transport at ER-PM junctions. The authors make the additional interesting observation that GRAMD1a and GRAMD2a localize to different ER-PM membrane contact sites. The authors further demonstrate that GRAMD2a pre-marks PI(4,5)P2-enriched ER-PM membrane contact sites for store-operated calcium entry, while GRAMD1a does not co-localize with PI(4,5)P2 regions.

The manuscript is overall interesting and in principle suitable for publication in *ELife*. Nevertheless, the characterization of GRAMD2a KO needs to be made in some more detail, showing whether basal Ca^2+^ levels in the cytosol and receptor or thapsigargin-triggered Ca^2+^ signaling is altered. Also, a statistical analysis of some of the observations in the experiments in [Figures 1](#fig1){ref-type="fig"}--[5](#fig5){ref-type="fig"} needs to be made more quantitatively. While the authors quantify some images they do not quantify other results and still make quantitative statements about them in the text (e.g. significant). Replicates of the individual experiments are, for the most part, not included, and at one point they state data not shown which should be added in Supplementary figures. There are also a few controls missing. Additionally, the authors do not adhere to the order of the figures in the text, which makes it very difficult for the reader to find the piece of data that the text refers to.

Specific Revisions:

1\) GRAMD2a KO cells need more characterization.

a\) In [Figure 7](#fig7){ref-type="fig"}, the single clone could have reduced amount of STIM1 and rescue by GRAMD2a overexpression could result from expansion of MCSs, so please show images to demonstrate normal looking MCSs and document protein levels.

b\) Please measure SOCE responses in the KO cells compared to WT

2\) The claim that GRAMD2a facilitates or is required for STIM1 recruitment to contact sites seems premature. Please quantitate the analysis to show that most or all of the recruited STIM1 overlaps with GRAMD2a (using total pixel overlap) and provide proper statistical analysis throughout.

3\) The localization patterns in [Figure 2B and 2C](#fig2){ref-type="fig"} need to be quantitated and additional quantitation is needed throughout (see point 2).

4\) Does GRAMD2a bind to the PM via a GRAM domain-PIP-lipid interaction? To address this they need to show that deleting or mutating the GRAM domain inhibits binding.

5\) Please show something about how the STIM1 separates itself from GRAMD2a during its accumulation at the PM; i.e., are they really part of the same ER structure? Perhaps coexpressing Sec61 marker would suffice. Also, the criteria for judging that GRAM proteins were localized to MCSs was never explicitly stated. Some EM could help a lot here, though it would likely take more than 2 months. A fluorescent marker (MAPPER, or a luminal ER marker) to mark these sites should be tried.

Points that could probably be handled by discussion in the text:

1\) Please offer possible explanation as to why STIM1-deltaK forms puncta in cells not overexpressing Orai, contrary to previous studies. For someone in the field, this result will look very suspicious.

2\) They should also discuss why GRAMD2a KO does not reduce number of puncta if it acts as a tether.

Reviewer \#1

This study shows that GRAMD1a and GRAMD2a localize to distinct ER-plasma membrane contact sites in human cells. Targeting of GRAMD2a to contact sites is dependent on PIP2 and the cytoplasmic domain of GRAMD2a was found to bind PIPs in vitro. GRAMD1a targeting does not seem to be dependent on PIP2. The study goes on to investigate the role of GRAMD2a in store operated calcium entry (SOCE). It shows that GRAMD2a marks contact sites where STIM1 is recruited during SOCE and it is suggested that GRAMD2a is required for the efficient PM translocation of STIM1. Overall, this is very well done and clearly presented study. However, the claim that GRAMD2a plays a role in STIM1 enrichment at contact sites, which is the most interesting aspect of this work, is not yet convincing.

1\) A trivial explanation for the results in [Figure 7A,B](#fig7){ref-type="fig"} could be that STIM1 levels are significantly reduced in GRAMD2a KO cells compared to control cells. This could explain why the average size and intensity of STIM1 puncta is reduced in GRAMD2a KO cells but the total number of puncta is not reduced.

2\) [Figure 5B](#fig5){ref-type="fig"} shows two examples of STIM1 recruitment to the plasma membrane following TG treatment. In both cases, roughly half of STIM1 puncta form at sites that do not appear to be marked by GRAMD2a. Of course, it is possible that the amount of GRAMD2a at these sites is below the level of detection but it is just as likely that GRAMD2a is not necessary for STIM1 recruitment. Since STIM1 puncta at sites that not do contain GRAMD2a seem about as bright and large as the others, the claim that GRAMD2a facilitates or is required for STIM1 recruitment to contact sites seems premature.

Reviewer \#2

The study by Besprozvannaya and colleagues describes the discovery of a new group of GRAM-domain containing proteins. This work is important as it shows a clear role, particularly of GRAMD2a, in controlling the localization and translocation of STIM1 proteins. The findings in the study strongly argue that GRAMD2a is part of a core machinery that sets up and regulates Ca^2+^/STIM1 signaling and potentially lipid transport at ER-PM junctions. The authors make the additional interesting observation that GRAMD1a and GRAMD2a localize to different ER-PM membrane contact sites. The authors further demonstrate that GRAMD2a pre-marks PI(4,5)P2-enriched ER-PM membrane contact sites for store-operated calcium entry, while GRAMD1a does not co-localize with PI(4,5)P2 regions.

The manuscript is overall interesting and in principle suitable for publication in *ELife*. Nevertheless, the characterization of GRAMD2a KO needs to be made in some more detail, showing whether basal Ca^2+^ levels in the cytosol and receptor or thapsigargin-triggered Ca^2+^ signaling is altered. Also, a statistics analysis of some of the observations in the experiments in [Figures 1](#fig1){ref-type="fig"}--[5](#fig5){ref-type="fig"} needs to be made more quantitatively. While the authors quantify some images they do not quantify other results and still make quantitative statements about them in the text (e.g. significant). Replicates of the individual experiments are, for the most part, not included, and at one point they state data not shown which should be added in Supplementary figures. There are also a few controls missing. Additionally, the authors do not adhere to the order of the figures in the text, which makes it very difficult for the reader to find the piece of data that the text refers to.

Major Concerns:

\- A main piece of data that should be added is a functional characterization of the GRAMD2a KO. As mentioned above, they should measure both basal Ca^2+^ levels and Ca^2+^ kinetics in KO and control cells.

\- The authors state that GRAMD1a-eGFP is observed in focal structures at the periphery of cells in [Figure 1C](#fig1){ref-type="fig"}. In the images, however, it looks like especially the co-localization of GRAMD1a-eGFP and GRAMD2a-eGFP with Sec61beta-Ch is rather at the center of the ER structures. This is also true for [Figure 1D](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}. To be able to make this conclusion, the authors need to quantify the co-localization at the center and the periphery separately, analyzing the percentage of GRAMD1a and GRAMD2a with BFP-Sec61beta and Lyn-Ch. After quantification of the images the authors should add in the text more clearly how many repetitions they did (independent experiments/wells/images). The authors do not comment on the fact that the ER maker in [Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"} and 1C looks very different. Are there morphology changes in cells overexpressing GRAMD1a-GFP?

\- The authors claim that in [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"} the co-localization corresponds to regions of cortical ER. To make this point it would be important to include a non-cortical ER co-localization and then quantify both conditions.

\- The distances on the line scan are quite large. Some puncta the authors report are 5µm in size according to the data the authors present, is this correct? Is this only in cells that overexpress a lot of the respective proteins? (i.e. in [Figure 2D](#fig2){ref-type="fig"}).

\- The authors state that a similar localization pattern is observed in [Figure 2B](#fig2){ref-type="fig"} and in 2C. Such a statement can only be made if the authors include a quantification of the co-localization pattern.

\- The levels of GRAMD1a-GFP expression in [Figure 2D](#fig2){ref-type="fig"} (and [Figure 2---figure supplement 1B and D](#fig2s1){ref-type="fig"}) are low and not comparable with the levels of expression of GRAMD2a-eGFP. Could that be the reason why no significant co-localization with E-Syt3-Ch is observed?

\- In [Figure 4](#fig4){ref-type="fig"} the localization of GRAMD2a-Ch/GRAMD1a-Ch is very different from CFP-PH-PLC. Since E-Syt2/3 are also known to localize at PI(4,5)P2-enriched ER-PM contact sites, it might be useful to add this marker for the co-localization analysis.

\- The authors use a liposome binding assay to assess whether GRAMD2a biding of PI(4)P and PI(4,5)P2 is specific. This assay seems to lack a non-binding control protein. The authors may include GRAMD1a-Ch as a control since it is not supposed to bind these lipids (as claimed in [Figure 4B](#fig4){ref-type="fig"}). Another useful control for in vitro binding comparison could be E-Syt2/3.

\- In [Figure 4F](#fig4){ref-type="fig"} the assay seems non-specific for 15% pf PI(4)P and PI(4,5)P2. The authors do not comment on that observation. Do they think it is a charge interaction mostly or a specific PIP2 binding interaction?

\- The authors state that GRAMD2a binds to the PM via a GRAM domain -PIP-lipid interaction. To make this claim, they need to delete the GRAM domain and show a failure of binding ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}).

\- The sentence that GRAMD2a uniquely marks SOCE-specific ER-PM MCSs (subsection "GRAMD2a pre-marks ER-PM contacts specialized for SOCE***"***) is not backed by data shown up to this point. The conclusion can only be made later.

\- Throughout the manuscript the authors prefer to show representative images of their results rather than a quantification of biological replicates. In [Figure 7B](#fig7){ref-type="fig"} the authors do not show any images and only show quantification of the results. To get a better understanding of the results in 7B the authors should include representative images of the quantified area. They also should perform throughout the study quantifications of images if they want to be able to use the term \"significant\".

Reviewer \#3

This is an interesting paper that proposes a role for GRAM-domain proteins in specializing ER-plasma membrane contact sites (MCSs) for store-operated calcium entry (SOCE). The molecular signature of MCSs that regulate SOCE is a topic of wide interest. Previous work by De Camilli\'s group has shown that the E-Syt proteins act as tethers to stabilize MCSs where the ER Ca^2+^ sensor STIM1 localizes. Surprisingly, E-syt knockdown reduced the number of MCSs without significantly reducing SOCE, suggesting there may be a subset of E-Syt+ sites that are specialized to conduct Ca. This paper proposes that GRAMD2a is a MCS tether that serves this function. The authors show that GRAMD2a colocalizes with E-Syt2/3 at MCSs in a PIP2-dependent way. After store depletion STIM1 is recruited initially to GRAMD2a sites, while GRAMD2a KO is associated with reduced STIM1 recruitment. On this basis they conclude that GRAMD2a pre-marks and specializes a subset of MCSs for SOCE.

Overall, these studies have been carefully done and are well presented. The non-overlapping localization of GRAMD1a and 2a and their different dependencies on PIP2 are clear. However, based on the data presented I am not convinced of the specific role of GRAMD2a in marking sites of SOCE, and have a number of questions related to the main conclusions that need to be addressed.

1\) The presence of GRAMD1a and 2a at ER-PM contacts needs to be demonstrated by EM. The conclusion is currently based on TIRF which only has a resolution of 100-200 nm and cannot resolve MCSs. EM is the standard for establishing the presence of specific proteins at ER-PM contacts, and was used in the initial studies of E-Syts and STIM proteins (Giordano et al., 2013; Wu et al., JCB 174:803, 2006). In addition, this would help test the authors\' speculation that GRAMD2a recruits STIM1 to MCSs by enforcing a particular geometry on the junction.

2\) The authors conclude the GRAM domain mediates the interaction of GRAMD2a with PIPs in the PM, but do not directly test this by mutating or deleting the domain. This should be done, especially as GRAMD1a does not require PIP2 for its localization.

3\) GRAMD2a is referred to as an ER-PM tether, but the only direct evidence for this is that its overexpression increases the size of ER-PM contacts ([Figure 5A](#fig5){ref-type="fig"}). At presumably much lower levels of endogenous expression, does it actually have this function? In the GRAMD2a knockout cells, the number of MCSs is not affected ([Figure 7](#fig7){ref-type="fig"}), which does not add support to its function as a tether. A possible complication here is that STIM1 was also overexpressed, which is known to distort ER-PM contacts. Does GRAMD2a KO reduce the number of MCSs when STIM1 is not expressed? MAPPER or a luminal ER marker might be useful here.

4\) A major point is that GRAMD2a helps recruit STIM1 to MCSs, but the underlying mechanism is completely unknown. Some additional information is needed, especially since the colocalization of the two proteins declines with time. Does GRAMD2a bind to STIM1, either directly or as part of a complex? Are the two proteins actually part of the same MCS? If so, does the MCS expand after arrival of STIM1, with STIM1 entering the new area? This could be investigated with an ER marker or a marker for ER-PM contacts (e.g., MAPPER). Again, EM would be very helpful here.

5\) [Figure 7](#fig7){ref-type="fig"} shows reduced recruitment of STIM1 in a single GRAMD2a KO clone, suggesting that endogenous GRAMD2a helps recruit STIM1 to the MCSs. The only argument against this being a clonal artifact is that the STIM1 response is \"rescued\" by transient transfection with GRAMD2a-GFP. However, this overexpression may compensate for the low recruitment in the KO by increasing MCS size. The authors need to show that GRAMD2a expression does not alter the size of the MCSs and is thus a true rescue of function.

6\) To support a role for GRAMD2a in SOCE, it is essential to compare Ca^2+^ influx in response to store depletion in GRAMD2a WT and KO cells, without overexpressing STIM1. This will provide the strongest test of whether endogenous GRAMD2a is actually essential for SOCE.

7\) It is very surprising that Ch-STIM1deltaK forms puncta in response to Ca^2+^ store depletion ([Figure 6](#fig6){ref-type="fig"}). Several studies (e.g., Liou et al., 2007; Park et al., 2009) have shown that STIM1-deltaK by itself does not localize to ER-PM contacts; if Orai is also present it binds STIM1-deltaK and the proteins trap each other. It seems highly unlikely that COS7 cells express enough endogenous Orai to account for the puncta, so the question is, what do they represent and are they actually at the PM? A more interpretable experiment would be to coexpress Orai1 so that STIM1-deltaK/Orai complexes can form without the need for PIP2, and ask whether the clusters fail to colocalize with GRAMD2a.

8\) To conclude that \"GRAMD2a pre-marks sites of STIM1 localization at ER-PM contacts\", it is necessary to show that most or all of STIM1 that ends up at the PM is recruited to GRAMD2a-positive sites. Otherwise, STIM1 may be responding to something else which happens to partially colocalize with GRAMD2a. How much STIM1 localizes to puncta that are not associated with GRAMD2a?

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"GRAM domain proteins specialize functionally distinct ER-PM contact sites in human cells\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by Suzanne Pfeffer as Reviewing Editor and Randy Schekman as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Tobias Meyer (Reviewer \#2).

The reviewers discussed the reviews with one another and the Reviewing Editor drafted this decision in the hopes that you can prepare a revised submission. We hope you will be able to submit the revised version within two months that highlights the stronger aspects of the current story and addresses the comments here from Reviewer \#1. We try hard not to support multiple rounds of reviews, but this expert referee\'s comments seemed serious enough that additional revision is required. Overall, this reviewer was less convinced now that GRAMD2a specifically marks ER-PM MCSs for SOCE, as the paper concludes. Specifically:

1\) The first question was whether expression of the mCh-STIM1 (not endogenous STIM1 -- subsection "GRAMD2a facilitates STIM1 recruitment during SOCE", [Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}) was lower in the single GRAMD2a KO clone. It is not possible to judge this from [Figure 7A](#fig7){ref-type="fig"} because the data are all normalized to initial fluorescence. STIM1 overexpression increases the area of MCSs and this is seen in [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}; reduced expression of mCh-STIM1 in the KO clone could potentially explain the decreased STIM1 puncta area. The second question was whether GRAMD1a overexpression could have increased the size of MCSs beyond control size, which might account for the increased recruitment of mCh-STIM1 to the PM. Please address these questions.

2\) The new calcium measurements have serious problems and overall the results are not consistent with the evidence that GRAMD2a knockout greatly inhibits STIM1 accumulation at ER-PM contact sites, and do not support the contention that GRAMD2a KO affects Ca^2+^ homeostasis more generally. The authors see a slight decrease in SOCE in GRAMD2a KO cells when measured by GECO-Orai1 ([Figure 7C](#fig7){ref-type="fig"}) and conclude this is consistent with the inhibition of STIM1 localization. There are a couple of problems here. First, the difference between control and KO is very slight. Given the profound inhibition of STIM1 translocation in 7A, and the fact that SOCE is a highly nonlinear function of STIM1 binding to Orai1, one would expect a nearly complete elimination of SOCE in KO cells. More importantly, overexpressing Orai1 without coexpressing STIM1 actually inhibits SOCE, presumably because an excess of Orai1 \"dilutes\" the pool of endogenous STIM1 and reduces the STIM1:Orai1 binding stoichiometry below the level needed to open the channel (see Hoover and Lewis, PNAS 108:13299, 2011; Li Z et al. J Biol Chem 282:29448, 2007; Soboloff et al. J Biol Chem 281:20661, 2006). Such a dilution effect would explain why Ca influx is slightly reduced with GECO-Orai1 overexpression, but not when Ca is measured by Lck-GCaMP or fluo-4 (and endogenous Orai and STIM levels are maintained). Thus, the slight inhibition of SOCE with GECO-Orai1 cannot be attributed to the absence of GRAMD2a.

The authors report an increase in SOCE in GRAMD2a KO cells, when Ca^2+^ is measured by Lck-GCaMP or fluo-4 ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}), and suggest that GRAMD2a may affect Ca^2+^ homeostasis more generally. However, the measurements of SOCE appear flawed. The classic hallmark of SOCE is that after stores are depleted with TG and Ca^2+^ is readded, the Ca^2+^ level overshoots the baseline. However, in [Figure 7C](#fig7){ref-type="fig"} as well as [Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}, the apparent Ca^2+^ level in control cells actually drops below baseline after Ca readdition. In the supplementary figure, the baseline Ca is also not stable, precluding a simple interpretation. Overall, these measurements are not convincing.

We suggest repeating these measurements in control and KO cells using a ratiometric indicator like fura-2, which is much more resistant to artifacts from differential dye loading, bleaching, illumination fluctuations, stray light, etc. Show that the control response is consistent with SOCE. If the KO response is larger than control, then further experiments will have to be done to reconcile the result with the apparent inhibition of STIM1 translocation.

Based on the evidence at this point, the reviewers felt that the conclusion that GRAMD2a really acts as a \"master tether\" that specifies a subset of E-syt MCSs for SOCE is overstated (Discussion section paragraph two). In the absence of GRAMD2a there are still many STIM1 puncta ([Figure 7B](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}); apparently, GRAMD2a is not required for STIM1 recruitment, although it may help promote it in some way. The new Ca^2+^ imaging data do not show a strong inhibition of SOCE in the absence of GRAMD2a. Taken together, a role of GRAMD2a in specifying sites for SOCE seems questionable at this stage.

Subsection "GRAMD2a pre-marks ER-PM contacts specialized for SOCE", final paragraph. Li et al. did not report TG-induced STIM1deltaK PM translocation in the absence of Orai1 overexpression. They overexpressed Orai1-mOrange.

Subsection "ER Ca^2+^950 depletion and PI(4,5)P2 depletion experiments" second paragraph: Ca^2+^ concentrations should be mM, not µM.

Please specify which GECO-Orai1 construct was used (there are two in the Dynes et al. paper). Also, specify which GCaMP was used for the Lck-GCaMP experiments (there are many).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"GRAM domain proteins specialize functionally distinct ER-PM contact sites in human cells\" for consideration by *eLife*. Your article has been reviewed by one peer reviewer, and the evaluation has been overseen by a Reviewing Editor and Randy Schekman as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. While we hate to ask for any additional work after revision, the key reviewer felt very strongly that the conclusions are not supported by the current data and a single experiment has the potential to quickly rectify this issue.

First, the reviewers felt that you have responded in a satisfactory way to points 1 and 2.

Regarding Point 3: The scientific basis for rating the quality as low was Ca^2+^ below baseline even when Ca^2+^ is re-added to WT in [Figure 7B](#fig7){ref-type="fig"} left, and the lack of a steady Ca^2+^ baseline at the start of the experiment in [Figure 7B](#fig7){ref-type="fig"} right.

In the revision, the authors now conclude that Ca^2+^ homeostasis is somehow different in U2OS cells compared to other cells like HEK or HeLa. This is not justified based on the sparse data that are presented. U2OS cells show very similar TG responses to HEK and HeLa; see Chen et al., Sci. Reports 6:22142, 2016; Supplementary Figure S1B. So this is not a cell type difference, but more likely has something to do with the way the cells have been treated. In the experience of the expert reviewer with many different cell types, basal Ca^2+^ can become elevated simply by plating cells on polylysine-coated coverslips, or flowing solutions past them, and one has to be careful not to stimulate Ca^2+^ signaling through these manipulations. The new fluo-4 data from HEK293 cells look great, but they do not validate the aberrant U2OS responses in [Figure 7B](#fig7){ref-type="fig"}. Also, the low P values comparing responses in WT vs. KO cells do not indicate that the \"data are solid\"; they merely indicate the two response are significantly different, but not why they differ. If one set of measurements is flawed, significant differences can occur, but they do not necessarily result from the KO. So this is still a problem that needs to be fixed to enable a meaningful comparison of WT and KO responses.

The new E-syt1 experiment is interesting, and does suggest that Ca^2+^ may be elevated in KO cells in the resting state. A likely explanation for both the TG and E-syt1 results is that the Ca^2+^ stores in the U2OS cells after plating are relatively empty, which prevents TG from releasing any more Ca^2+^ from the ER while stimulating tonic influx through SOCE. This also explains why Ca^2+^ drops inside when Ca^2+^ is removed outside ([Figure 7B](#fig7){ref-type="fig"}). It is unfortunate the authors did not take the suggestion of recording Ca^2+^ responses using fura-2, which would have indicated any differences in basal Ca^2+^ and allowed them to compare resting Ca^2+^ in WT vs KO in a direct way. (An elevated basal Ca^2+^ is not detectable in [Figure 7B](#fig7){ref-type="fig"} because the data are all normalized to the initial fluorescence).

The reviewers believe that the story will elicit substantial interest and further work to determine the underlying mechanisms. However, the SOCE data in U2OS cells cannot yet be interpreted. We suggest the following single experiment to clear this up (and to avoid misconceptions about Ca^2+^ handling in U2OS cells): Please measure the SOCE responses using fura-2, as suggested before. This should not be difficult: it should only take a few days and will go far to clarify the conclusions of this story.

10.7554/eLife.31019.034

Author response

> Specific Revisions:
>
> 1\) GRAMD2a KO cells need more characterization.
>
> a\) In [Figure 7](#fig7){ref-type="fig"}, the single clone could have reduced amount of STIM1 and rescue by GRAMD2a overexpression could result from expansion of MCSs, so please show images to demonstrate normal looking MCSs and document protein levels.

We examined endogenous STIM1 levels using Western analysis with an anti-STIM1 monoclonal antibody in control U2OS and GRAMD2a KO cells. This analysis showed that STIM1 levels are comparable in GRAMD2a KO cells and control wild type cells ([Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}). In addition, the STIM1 translocation experiments, shown in [Figure 7A and 7B](#fig7){ref-type="fig"}, were performed with transfected overexpressed mCherry-STIM1.

We used TIRF microscopy to quantify the total amount of ER-PM contact in U2OS wildtype and GRAMD2a KO cells. Using this analysis, the total area of cortical ER is comparable between control and GRAMD2a KO cells and these data are presented in [Figure 7---figure supplement 1E](#fig7s1){ref-type="fig"}.

> b\) Please measure SOCE responses in the KO cells compared to WT

We measured SOCE-specific calcium influx across the PM using a GECO- Orai1 and observed that there was a small, reproducible and significant reduction in Orai1-specific Ca^2+^ influx in GRAMD2a KO cells as compared to wildtype cells ([Figure 7C](#fig7){ref-type="fig"}). These findings are consistent with the defective STIM1 translocation observed in GRAMD2a KO cells and with our conclusion that GRAMD2a is a SOCE-specific ER-PM tether.

We also measured total calcium influx over the PM as well as total cytosolic calcium following TG treatment ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}). We observed that in contrast to Orai1, there was a significant TG-dependent increase in both total calcium influx over the PM and total cytosolic calcium in GRAMD2a KO cells as compared to control cells. This finding suggests that loss of GRAMD2a affects calcium homeostasis more generally, potentially via altered PIP lipid homeostasis and/or by alterations in the activity of other calcium regulatory networks that impinge on other Ca^2+^ channels, such as TRP. These observations are interesting and indicate a broader role for GRAMD2a; however, a detailed analysis of the mechanisms underlying these phenotypes is beyond the scope of the manuscript.

> 2\) The claim that GRAMD2a facilitates or is required for STIM1 recruitment to contact sites seems premature. Please quantitate the analysis to show that most or all of the recruited STIM1 overlaps with GRAMD2a (using total pixel overlap) and provide proper statistical analysis throughout.

We have performed the requested quantification and it is now presented in a new Table 1 embedded in the revised manuscript. Proper statistical analysis is provided throughout the manuscript.

> 3\) The localization patterns in [Figure 2B and 2C](#fig2){ref-type="fig"} need to be quantitated and additional quantitation is needed throughout (see point 2).

We performed the two-tailed t-test on localization of GRAMD1a/2a with E- Syt2/3 in [Figure 2B and 2C](#fig2){ref-type="fig"}. Co-localization quantification (total pixel overlap) of GRAMD2a with E-Syt2/3 shown was statistically different from GRAMD1a with E-Sty2/3.

> 4\) Does GRAMD2a bind to the PM via a GRAM domain-PIP-lipid interaction? To address this they need to show that deleting or mutating the GRAM domain inhibits binding.

Our deletional analysis of GRAMD2a and GRAMD1a indicate that their predicted respective GRAM domains are necessary for targeting to the PM ([Figure 1E and 1F](#fig1){ref-type="fig"}), substantiating our conclusion that they are ER-PM tethers that, in the case of GRAMD2a, directly tethers to the PM via PIP lipids.

> 5\) Please show something about how the STIM1 separates itself from GRAMD2a during its accumulation at the PM; i.e., are they really part of the same ER structure? Perhaps coexpressing Sec61 marker would suffice. Also, the criteria for judging that GRAM proteins were localized to MCSs was never explicitly stated. Some EM could help a lot here, though it would likely take more than 2 months. A fluorescent marker (MAPPER, or a luminal ER marker) to mark these sites should be tried.

Line-scan analysis of individual puncta of GRAMD2a indicates that GRAMD2a and STIM1 share a ER-PM contact site subsequent to their spatial resolution at later time points of TG treatment ([Figure 5D](#fig5){ref-type="fig"}).

Our most stringent data used to conclude that GRAMD2a and GRAMD1a are localized to ER-PM contacts was TIRF analysis, which is a standard analysis PM-linked events. All other data, including line scans demonstrating the co-localization of these components with both PM and ER are also consistent with this conclusion. In our hands, MAPPER expression perturbs/expands the cortical ER and thus is not suitable. EM analysis would indeed be time and resource consuming. We chose to use our resources to address questions that were completely unknown, such as calcium dynamics in GRAMD2a KO cells.

> Points that could probably be handled by discussion in the text:
>
> 1\) Please offer possible explanation as to why STIM1-deltaK forms puncta in cells not overexpressing Orai, contrary to previous studies. For someone in the field, this result will look very suspicious.

Many labs studying SOCE work with HeLa or Hek293 cell lines. Our analysis was performed using COS7 and U2OS cells. Our data demonstrate that in COS7 cells STIMΔK is capable of translocating to the PM after ER calcium depletion, while, as already reported in the field, STIM1ΔK does not translocate to the PM under similar conditions in HeLa cells. These data are now included as [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}. We hypothesize that differences in the endogenous expression of STIM1 and Orai1 protein account for this apparent discrepancy between different cell lines.

> 2\) They should also discuss why GRAMD2a KO does not reduce number of puncta if it acts as a tether.

We have included the following statements in our revised discussion in response:

"Although the kinetics and extent of STIM1 recruitment are altered in the absence of GRAMD2a, the number of STIM1 puncta is not affected in GRAMD2a KO cells. We speculate that this GRAMD2a-independent recruitment of STIM1 is a consequence of functional redundancy of additional independent ER-PM tethers, such as E-Syt~1/2~/3 and oxysterol- binding proteins (OSBP)/OSBP-related proteins (Saheki and De Camilli, 2017a)."

"The basis for the rapid and selective recruitment of STIM1 to GRAMD2a- marked contacts may lie in the geometry of the ER-PM contact site created by the GRAMD2a tether and/or its influence on PIP lipid dynamics/concentration. Specifically, given its small size and simple domain structure, GRAMD2a is likely to create a tight ER-PM junction, which may facilitate STIM1 recruitment, consistent with the observed preference of STIM1 for the relatively narrow junction created by E-Syt1 over E-Syt2/3 (Fernandez-Busnadiego et al., 2015)."

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The reviewers discussed the reviews with one another and the Reviewing Editor drafted this decision in the hopes that you can prepare a revised submission. We hope you will be able to submit the revised version within two months that highlights the stronger aspects of the current story and addresses the comments here from Reviewer \#1. We try hard not to support multiple rounds of reviews, but this expert referee\'s comments seemed serious enough that additional revision is required. Overall, this reviewer was less convinced now that GRAMD2a specifically marks ER-PM MCSs for SOCE, as the paper concludes. Specifically:
>
> 1\) The first question was whether expression of the mCh-STIM1 (not endogenous STIM1 -- subsection "GRAMD2a facilitates STIM1 recruitment during SOCE", [Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}) was lower in the single GRAMD2a KO clone. It is not possible to judge this from [Figure 7A](#fig7){ref-type="fig"} because the data are all normalized to initial fluorescence. STIM1 overexpression increases the area of MCSs and this is seen in [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}; reduced expression of mCh-STIM1 in the KO clone could potentially explain the decreased STIM1 puncta area.

Measuring endogenous STIM1 made a lot of sense to us and in fact there seems to be a slight elevation in the STIM1 levels in the GRAMD2a KO cells. Nevertheless, we performed Western blots on both endogenous and overexpressed mCherry-STIM1 extracts from wild type and GRAMD2a KO cells under conditions where we observed defective STIM1 translocation in the KO cells and did not observe any significant difference in the expression levels of mCherry-STIM1 ([Figure 7---figure supplement 1D and E](#fig7s1){ref-type="fig"}).

> The second question was whether GRAMD1a overexpression could have increased the size of MCSs beyond control size, which might account for the increased recruitment of mCh-STIM1 to the PM. Please address these questions.

We selected cells that had apparently normal ER-PM contacts site density and area. This is documented in [Figure 1D](#fig1){ref-type="fig"} low expression (0.1 ug/dish) and [Figure 5A](#fig5){ref-type="fig"} high expression (1.0 ug). Under both these conditions we observe that GRAMD2a pre-marks contacts where STIM1 is recruited in cells. Also, [Figure 5B](#fig5){ref-type="fig"} documents that under resting conditions with GRAMD2a low expression (low expression was used in all experiments with the exception of [Figure 5B](#fig5){ref-type="fig"}) STIM1 is diffusely localized to the ER, indicating that overexpression of GRAMD2a is not sufficient for STIM1 recruitment.

> 2\) The new calcium measurements have serious problems and overall the results are not consistent with the evidence that GRAMD2a knockout greatly inhibits STIM1 accumulation at ER-PM contact sites, and do not support the contention that GRAMD2a KO affects Ca^2+^ homeostasis more generally. The authors see a slight decrease in SOCE in GRAMD2a KO cells when measured by GECO-Orai1 ([Figure 7C](#fig7){ref-type="fig"}) and conclude this is consistent with the inhibition of STIM1 localization. There are a couple of problems here. First, the difference between control and KO is very slight. Given the profound inhibition of STIM1 translocation in 7A, and the fact that SOCE is a highly nonlinear function of STIM1 binding to Orai1, one would expect a nearly complete elimination of SOCE in KO cells. More importantly, overexpressing Orai1 without coexpressing STIM1 actually inhibits SOCE, presumably because an excess of Orai1 \"dilutes\" the pool of endogenous STIM1 and reduces the STIM1:Orai1 binding stoichiometry below the level needed to open the channel (see Hoover and Lewis, PNAS 108:13299, 2011; Li Z et al. J Biol Chem 282:29448, 2007; Soboloff et al. J Biol Chem 281:20661, 2006). Such a dilution effect would explain why Ca influx is slightly reduced with GECO-Orai1 overexpression, but not when Ca is measured by Lck-GCaMP or fluo-4 (and endogenous Orai and STIM levels are maintained). Thus, the slight inhibition of SOCE with GECO-Orai1 cannot be attributed to the absence of GRAMD2a.
>
> \[...\]
>
> Based on the evidence at this point, the reviewers felt that the conclusion that GRAMD2a really acts as a \"master tether\" that specifies a subset of E-syt MCSs for SOCE is overstated (Discussion section paragraph two). In the absence of GRAMD2a there are still many STIM1 puncta ([Figure 7B](#fig7){ref-type="fig"} and [Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}); apparently, GRAMD2a is not required for STIM1 recruitment, although it may help promote it in some way. The new Ca^2+^ imaging data do not show a strong inhibition of SOCE in the absence of GRAMD2a. Taken together, a role of GRAMD2a in specifying sites for SOCE seems questionable at this stage.

To address concerns that the system we used for measuring Ca^2+^ is somehow fundamentally flawed, we measured the SOCE response in the HEK293 cell line, in which the conical SOCE has been defined. As shown in Figure 7---figure supplement 1F, we can reproduce the stereotypical SOCE response in this line using our experimental conditions, which indicates that the trivial explanations provided above do not account for the different response observed in U2OS cells. As expressed in our rebuttal letter dated November 12th above, we are also willing to share all of our raw data, which is compiled in [Figure 7B](#fig7){ref-type="fig"} and Figure 7---figure supplement 1F. In the raw movies, it is apparent that there are no "bleaching, focus drift, movement, etc" issues. Also, the Ca^2+^ responses between wild type and GRAMD2a KO cells are significantly different (p values 10-5)-see [Figure 7](#fig7){ref-type="fig"} legend for details, which indicates that our data are "solid". We have also added a new experiment examining E-Syt1 localization, which represents an independent approach to test the validity of our Ca^2+^ measurement data. It has been documented that under resting conditions E-Syt1 is localized diffusely in the ER but upon elevated cytosolic Ca^2+^ (independent of SOCE) it translocates to ER-PM contacts (Idevall-Hagren et al. 2105). [Figure 7C](#fig7){ref-type="fig"} and Figure 7---figure supplement 1G shows that under resting conditions, in contrast to wild type cells, E-Syt1 is constitutively localized at ER-PM contacts in GRAMD2a KO cells in a Ca^2+^ dependent manner, further substantiating our Ca^2+^ measurements and indicating that loss of GRAMD2a significantly alters the composition of ER-PM contacts.

We removed the GECO-Orai data because of the complication in interpretation resulting from overexpression of Orai. As stated above, we have performed additional experiments to address the specificity of the STIM1 and Ca^2+^ phenotypes in GRAMD2a knockout cells. We observe an additional defect in E-Syt1 localization, consistent with abberant Ca^2+^ homeostasis but we did not observe any apparent differences in PM PIP or cholesterol lipids or in E-Syt2/3 localization. Together we feel these data are consistent with a model in which GRAD2a functions as a ER-PM tether that organizes a PM domain devoted to Ca^2+^ handling.

> Subsection "GRAMD2a pre-marks ER-PM contacts specialized for SOCE", final paragraph. Li et al. did not report TG-induced STIM1deltaK PM translocation in the absence of Orai1 overexpression. They overexpressed Orai1-mOrange.

We have removed the citation and note that in HeLa cells where most of the STIM1deltaK work has been performed, we do not observe TG-induced translocation in the absence of overexpressed Orai, consistent with published work. However, we do observe in COS7 cells ([Figure 6A](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Thus, like the SOCE response in U2OS cells, our data indicate that different cell types are indeed different.

> Subsection "ER Ca^2+^950 depletion and PI(4,5)P2 depletion experiments" second paragraph: Ca^2+^ concentrations should be mM, not µM.

Done.

> Please specify which GECO-Orai1 construct was used (there are two in the Dynes et al. paper). Also, specify which GCaMP was used for the Lck-GCaMP experiments (there are many).

GECO-Orai data have been removed. We have clarified that we used Lck-GCaMP3G.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> First, the reviewers felt that you have responded in a satisfactory way to points 1 and 2.
>
> Regarding Point 3: The scientific basis for rating the quality as low was Ca^2+^ below baseline even when Ca^2+^ is re-added to WT in [Figure 7B](#fig7){ref-type="fig"} left, and the lack of a steady Ca^2+^ baseline at the start of the experiment in [Figure 7B](#fig7){ref-type="fig"} right.
>
> In the revision, the authors now conclude that Ca^2+^ homeostasis is somehow different in U2OS cells compared to other cells like HEK or HeLa. This is not justified based on the sparse data that are presented. U2OS cells show very similar TG responses to HEK and HeLa; see Chen et al., Sci. Reports 6:22142, 2016; Supplementary Figure S1B. So this is not a cell type difference, but more likely has something to do with the way the cells have been treated. In the experience of the expert reviewer with many different cell types, basal Ca^2+^ can become elevated simply by plating cells on polylysine-coated coverslips, or flowing solutions past them, and one has to be careful not to stimulate Ca^2+^ signaling through these manipulations. The new fluo-4 data from HEK293 cells look great, but they do not validate the aberrant U2OS responses in [Figure 7B](#fig7){ref-type="fig"}. Also, the low P values comparing responses in WT vs. KO cells do not indicate that the \"data are solid\"; they merely indicate the two response are significantly different, but not why they differ. If one set of measurements is flawed, significant differences can occur, but they do not necessarily result from the KO. So this is still a problem that needs to be fixed to enable a meaningful comparison of WT and KO responses.

We thank the expert reviewer for this full explanation and for pointing out published SOCE data in U2OS cells. Based on these comments and data, we recruited a collaborator to help us conduct the Fura-2 measurements as we do not have the appropriate instrumentation. In the course of the Fura-2 experiments, we determined that Fluo-4 and Llk-GcAMP3G data were indeed flawed as a consequence of technical issues and have been removed. As you will see in revised [Figure 7B](#fig7){ref-type="fig"}, using Fura-2, we did not observe a significant change in the SOCE response between WT and GRAMD2a KO cells.

> The new E-syt1 experiment is interesting, and does suggest that Ca^2+^ may be elevated in KO cells in the resting state. A likely explanation for both the TG and E-syt1 results is that the Ca^2+^ stores in the U2OS cells after plating are relatively empty, which prevents TG from releasing any more Ca^2+^ from the ER while stimulating tonic influx through SOCE. This also explains why Ca^2+^ drops inside when Ca^2+^ is removed outside ([Figure 7B](#fig7){ref-type="fig"}). It is unfortunate the authors did not take the suggestion of recording Ca^2+^ responses using fura-2, which would have indicated any differences in basal Ca^2+^ and allowed them to compare resting Ca^2+^ in WT vs KO in a direct way. (An elevated basal Ca^2+^ is not detectable in [Figure 7B](#fig7){ref-type="fig"} because the data are all normalized to the initial fluorescence).

Our Fura-2 data (not normalized to initial fluorescence -- only non-dye-loaded cell background subtracted) suggest that basal cytoplasmic Ca^2+^ is not significantly different between the WT and KO cells. The increased constitutive Ca^2+^-dependent ESyt1 PM localization in GRAMD2a KO cells suggest that Ca^2+^ may be altered proximal to the PM. This aberrant localization is likely a compensatory response to altered ER-PM contacts and may normalize Ca^2+^ homeostasis. At this point, we are hesitant to revisit Llk-GcAMP3G experiments given the general concern that the probe may not be a neutral reporter. Thus, the exact basis of the STIM1 and E-Syt-1 localization defects in GRAMD2a KO cells and their relationship to Ca^2+^ (and π (4,5)P2) homeostasis will require additional experimentation beyond the scope of the manuscript.
